AlphaMed, Inc.

États‑Unis d’Amérique

Retour au propriétaire

1-100 de 1 157 pour AlphaMed, Inc. et 2 filiales Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 1 139
        Marque 18
Juridiction
        États-Unis 585
        International 550
        Canada 22
Propriétaire / Filiale
Verily Life Sciences LLC 1 113
Nest Labs, Inc. 37
[Owner] AlphaMed, Inc. 7
Date
Nouveautés (dernières 4 semaines) 5
2026 août (MACJ) 1
2026 juillet 5
2026 juin 7
2026 avril 2
Voir plus
Classe IPC
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus 258
A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang 129
G02C 7/04 - Lentilles de contact pour les yeux 70
A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques 57
A61N 1/05 - Électrodes à implanter ou à introduire dans le corps, p. ex. électrode cardiaque 53
Voir plus
Classe NICE
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 15
09 - Appareils et instruments scientifiques et électriques 14
42 - Services scientifiques, technologiques et industriels, recherche et conception 13
38 - Services de télécommunications 11
10 - Appareils et instruments médicaux 3
Voir plus
Statut
En Instance 80
Enregistré / En vigueur 1 077
  1     2     3     ...     12        Prochaine page

1.

VERILY HEALTH

      
Numéro d'application 1930488
Statut Enregistrée
Date de dépôt 2026-02-05
Date d'enregistrement 2026-02-05
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 10 - Appareils et instruments médicaux
  • 16 - Papier, carton et produits en ces matières
  • 35 - Publicité; Affaires commerciales
  • 38 - Services de télécommunications
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; downloadable software for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; downloadable software using artificial intelligence for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; downloadable software for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; downloadable software using artificial intelligence for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; downloadable chatbot software using artificial intelligence for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; downloadable software for accessing and refreshing patient medical records from health information exchanges; downloadable software for data processing and analysis for use with medical clinical trials, research studies, and health management and treatment; downloadable software for clinical trial data collection, storage, and analysis; downloadable software using artificial intelligence for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; downloadable software to support treatment between a patient and provider, namely, software for sharing patient files and healthcare data; downloadable software using artificial intelligence for the capture and analysis of health data to improve patient care; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable software for using surgical equipment, namely, software for operating, controlling, monitoring, and analyzing and processing data from surgical equipment; downloadable video files in the fields of health, nutrition, wellness, medicine, scientific, and pharmaceuticals; downloadable printable educational materials in the fields of health, nutrition, wellness, medicine, scientific, and pharmaceuticals; downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable computer software for application and database integration. Wearable medical technological devices for the detection, monitoring, and management of biomarkers and health and physiological data, namely, wearable activity and biometric data trackers, wearable monitors and medical apparatus and instruments for monitoring vital signs, blood properties and respiratory properties and events; all the foregoing for medical use. Printed publications, namely, brochures, journals, reports, newsletters, booklets, magazines and teaching materials in the fields of health, nutrition, medicine, science, pharmaceuticals, and technology. Promoting public interest and awareness of issues, developments, and topics in the fields of health, nutrition, medicine, science, pharmaceuticals, and technology; data processing services in the field of healthcare; health care cost management and review services; managed care services, namely, electronic processing of healthcare information; updating and maintenance of information in registries; patient relationship management services. Telecommunication services, namely, transmission of voice, data, graphics, images, audio and video by means of telecommunications networks, wireless communication networks, and the internet; transmission of voice, data, graphics, images, audio and video related to health by means of telecommunications networks, wireless communication networks, and the Internet via a telecommunications platform; electronic transmission of messages and data; transmission of information by electronic communications networks; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data. Online publication of and providing non-downloadable publications in the nature of articles and presentations in the fields of health, nutrition, wellness, medicine, science, and pharmaceuticals via a website; providing non-downloadable educational videos in the fields of health, nutrition, wellness, medicine, science, and pharmaceuticals via a website; providing online non-downloadable educational videos in the fields of health, nutrition, wellness, medicine, science, and pharmaceuticals; online personal coaching services in the fields of health, nutrition, wellness, medicine, science, and pharmaceuticals. Software as a service (SAAS) featuring software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; software as a service (SAAS) featuring software for monitoring, tracking, and analyzing health, medical, genetic, movement, nutritional, wellness, geographic, health risk, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; software as a service (SAAS) featuring software using artificial intelligence (AI) for monitoring, tracking, and analyzing health, medical, genetic, movement, nutritional, wellness, geographic, health risk, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; software as a service (SAAS) featuring software for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; software as a service (SAAS) featuring software using artificial intelligence (AI) for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; software as a service (SAAS) featuring software for accessing and refreshing patient medical records from health information exchanges; software as a service (SAAS) featuring software for data processing and analysis for use with medical clinical trials, research studies, and health management and treatment; software as a service (SAAS) featuring software for clinical trial data collection, storage, and analysis; software as a service (SAAS) featuring software using artificial intelligence (AI) for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; software as a service (SAAS) featuring software for supporting treatment between a patient and provider, namely, software for sharing patient files and healthcare data; software as a service (SAAS) featuring software using artificial intelligence (AI) for the capture and analysis of health data to improve patient care; software as a service (SAAS) featuring software using artificial intelligence (AI) for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; software as a service (SAAS) featuring software using artificial intelligence (AI) for patient case management for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; software as a service (SAAS) featuring software for using surgical equipment; software as a service (SAAS) featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; application service provider featuring application programming interface (API) software; providing online non-downloadable software that enables users to enter, access, track, monitor and generate health and medical information and reports via an interactive website; medical research. Providing information about health and the management of health conditions; healthcare advisory services; healthcare services in the nature of real time medical diagnosis support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks; providing personalized healthcare and medical information in the fields of mental health, physical health, nutrition, wellness, diet and exercise, symptom, disease, and treatment management; providing personalized healthcare and medical information for use in optimizing the use of medication for health and wellness treatments by offering data featuring health, medical, genetic, movement, nutritional, wellness, geographic, health risk, and demographic information; medical services in the nature of providing health data analytics and care delivery data analytics and insights to patients, doctors, hospitals, and medical professionals for diagnostic and treatment purposes from a database; medical diagnostic testing, monitoring, and reporting services; medical testing and analysis for diagnostic and population health purposes provided by medical laboratories in the fields of oncology and virology; medical services, namely, screening, diagnosing or grading the severity of a disease or health condition based on image data; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.

2.

LOCAL NAVIGATION AIDS TO ASSIST ENDOSCOPISTS FINDING LOST POLYPS

      
Numéro d'application 19142508
Statut En instance
Date de dépôt 2024-02-12
Date de la première publication 2026-07-30
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Aizenberg, Natalia
  • Kelner, Ori
  • Zheng, Yuan
  • Goldenberg, Roman
  • Amit, Ron

Abrégé

A user-interface for visualizing a colonoscopy procedure includes a video region, a polyp annotation and identification graphic, and a lost polyp navigational aid. A live video feed received from a colonoscope is displayed in the video region. The polyp annotation depicts a location of a polyp within a colon and is presented on the live video feed. When the polyp is lost from the field of view (e.g., as a result of surgical tool insertion), the lost polyp navigation aid displays directions and/or signals to guide the endoscopist back to the lost polyp.

Classes IPC  ?

  • A61B 1/31 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments pour le rectum, p. ex. proctoscopes, sigmoïdoscopes
  • A61B 1/00 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments
  • G06T 7/73 - Détermination de la position ou de l'orientation des objets ou des caméras utilisant des procédés basés sur les caractéristiques

3.

FIELD EMISSION SOURCE FOR ION MOBILITY SPECTROMETRY

      
Numéro d'application 19144221
Statut En instance
Date de dépôt 2024-01-02
Date de la première publication 2026-07-23
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Krasnow, Benjamin

Abrégé

In one aspect, a field emission source is disclosed herein. The field emission source may include a field emission layer having at least one structure configured to emit electrons, a spacer contacting the field emission layer, and a window layer contacting the spacer and positioned opposed the at least one structure. The window layer may be transparent to electrons. Moreover, the field emission layer, the spacer, and the window layer may form an airtight cavity. In some cases, the field emission source may be used in an ion mobility spectrometer (IMS) system.

Classes IPC  ?

4.

INGESTIBLE DEVICE WITH SELF-ORIENTATION CAPABILITY IN AN IN VIVO ENVIRONMENT

      
Numéro d'application 19138048
Statut En instance
Date de dépôt 2023-12-12
Date de la première publication 2026-07-16
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Lee, Kye
  • Dennis, Joseph

Abrégé

Introduced here is an ingestible device (that is able to deliver medication directly into tissue along the gastrointestinal tract. Administration of a medication stored in the ingestible device may require that the ingestible device orient itself against the tissue. To accomplish this, the ingestible device may have an asymmetrically weighted formfactor. For example, the ingestible device may be weighted along an end (also called the “weighted end”) through which the needle extends in order to promote self-orientation.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

5.

pre

      
Numéro d'application 1927228
Statut Enregistrée
Date de dépôt 2026-02-12
Date d'enregistrement 2026-02-12
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Telecommunications access services; telecommunication services provided via Internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. Research services in the field of data analytics and machine learning, namely analysis of technical data relating to clinical trials, laboratory and genomics; data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SaaS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways. Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultation rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks.

6.

METADATA EXTRACTION USING LARGE LANGUAGE MODELS (LLMS)

      
Numéro d'application US2025060016
Numéro de publication 2026/147694
Statut Délivré - en vigueur
Date de dépôt 2025-12-17
Date de publication 2026-07-09
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Donhowe, Caitlin
  • Zhang, Liangliang

Abrégé

Introduced here is a system that is able to extract metadata from documents using LLMs. At a high level, the system obtains a file relating to a clinical trial. The system applies, to the file, a hash function to produce a hash value. Then, the system compares the hash value against hash values representing previously uploaded files to determine whether a matching hash value exists. In response to determining that no matching hash value exists, the system extracts an identifier for the clinical trial by applying an LLM to metadata of the file. The system then compares the identifier against identifiers of clinical trials to determine whether a matching identifier exists. Finally, in response to determining that no matching identifier exists, the generative platform prompts the user for information regarding the clinical trial.

Classes IPC  ?

  • G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
  • G06F 40/10 - Traitement de texte
  • G06F 40/30 - Analyse sémantique
  • G06F 40/40 - Traitement ou traduction du langage naturel
  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G16H 80/00 - TIC spécialement adaptées pour faciliter la communication entre les professionnels de la santé ou les patients, p. ex. pour le diagnostic collaboratif, la thérapie collaborative ou la surveillance collaborative de l’état de santé

7.

RETINAL IMAGE GENERATION BASED ON EYE MOTION MODELLING-BASED CAPTURE PARAMETERS

      
Numéro d'application US2025059777
Numéro de publication 2026/136313
Statut Délivré - en vigueur
Date de dépôt 2025-12-16
Date de publication 2026-06-25
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Yoshitake, Tadayuki
  • Zhou, Annie
  • Chen, Peter

Abrégé

Introduced here are approaches to generating an image with a fundus camera based on parameters determined through modeling of eye motion. The method captures a series of images to generate pupil position data over time. Using this data, the method determines a model for estimating pupil positions and predicts a time associated with a minimum pupil velocity. The method can estimate the pupil position at this time and generate a fundus camera configuration based on the position. The method can transmit a command to capture an image of the eye using the fundus camera configuration. By implementing these approaches, an imaging system can improve the quality of retinal imaging for patients with eye motion.

Classes IPC  ?

  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil
  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/13 - Microscopes ophtalmiques
  • A61B 5/16 - Dispositifs pour la psychotechnieTest des temps de réaction
  • G01N 15/1434 - Dispositions optiques
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux

8.

CREATING AN INTERFACE BETWEEN A CONTROL SYSTEM AND AN ELECTRONIC EYEMOUNTED OCULAR DEVICE ON PRE-EXISTING EYEGLASSES

      
Numéro d'application 19531292
Statut En instance
Date de dépôt 2026-02-05
Date de la première publication 2026-06-18
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Gutierrez, Christian
  • Azar, Dimitri

Abrégé

A modular system can be used with commercial eyeglasses to interface with an electronic eye-mounted ocular device and used to control and/or actuate the electronic eye-mounted ocular device, exchange data with the electronic eye-mounted ocular device, and/or charge the electronic eye-mounted ocular device. The modular system includes an electroactive stick-on component attachable to a portion of an eyeglasses lens; and an electronic system attachable to an eyeglass frame in electrical communication with the electroactive stick-on component.

Classes IPC  ?

  • G02C 11/00 - Accessoires non optiquesFixation de ceux-ci
  • G02C 7/04 - Lentilles de contact pour les yeux

9.

PRE

      
Numéro d'application 1922856
Statut Enregistrée
Date de dépôt 2026-01-08
Date d'enregistrement 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

10.

VERILY INTELLIGENCE

      
Numéro d'application 1921172
Statut Enregistrée
Date de dépôt 2026-01-08
Date d'enregistrement 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; downloadable software using artificial intelligence for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; downloadable software using artificial intelligence for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; downloadable chatbot software using artificial intelligence for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; downloadable software for accessing and refreshing patient medical records from health information exchanges; downloadable software using artificial intelligence for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; downloadable software for clinical trial data collection, storage, and analysis; downloadable software using artificial intelligence for the capture and analysis of health data to improve patient care. Providing online non-downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; providing online non-downloadable software using artificial intelligence for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; providing online non-downloadable software for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; providing temporary use of online non-downloadable chatbot software using artificial intelligence for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; providing online non-downloadable software for accessing and refreshing patient medical records from health information exchanges; providing online non-downloadable software using artificial intelligence for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; providing online non-downloadable software for clinical trial data collection, storage and analysis; providing online non-downloadable software using artificial intelligence for the capture and analysis of health data to improve patient care. Providing information about health and the management of health conditions; healthcare advisory services; healthcare services in the nature of real time medical diagnosis support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks; providing personalized healthcare and medical information in the fields of mental health, physical health, nutrition, wellness, diet and exercise, symptom, disease, and treatment management; providing personalized healthcare and medical information for use in optimizing the use of medication for health and wellness treatments by offering data featuring health, medical, genetic, movement, nutritional, wellness, geographic, health risk, and demographic information; medical services in the nature of providing a database featuring health data analytics and care delivery data analytics and insights to patients, doctors, hospitals, and medical professionals for diagnostic and treatment purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical diagnostic testing, monitoring, and reporting services; laboratory testing and analysis for diagnostic and population health purposes in the fields of oncology and virology; medical services, namely, screening, diagnosing or grading the severity of a disease or health condition based on image data; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.

11.

VIOLET

      
Numéro d'application 1921664
Statut Enregistrée
Date de dépôt 2026-01-08
Date d'enregistrement 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

12.

VERILY VIOLET

      
Numéro d'application 1922079
Statut Enregistrée
Date de dépôt 2026-01-08
Date d'enregistrement 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. Providing temporary use of on-line non-downloadable software and programs using artificial intelligence (AI) for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; providing online non-downloadable software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific, and pharmaceutical fields; providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

13.

PRE

      
Numéro d'application 1920413
Statut Enregistrée
Date de dépôt 2026-02-12
Date d'enregistrement 2026-02-12
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Telecommunications access services; telecommunication services provided via Internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. Research services in the field of data analytics and machine learning, namely analysis of technical data relating to clinical trials, laboratory and genomics; data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SaaS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks.

14.

PASSIVE INTRAOCULAR PRESSURE CONTROL AND ASSOCIATED SYSTEMS, DEVICES, AND METHODS

      
Numéro d'application 19418736
Statut En instance
Date de dépôt 2025-12-12
Date de la première publication 2026-04-16
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Samakar, Amirhossein
  • Mcguire, Allister

Abrégé

Devices, systems, and methods for passively regulating or controlling Intraocular Pressure (IOP) are provided. A device may be configured to be implanted or attached to a patient’s eye to provide regulated drainage of aqueous humor (AH) out of the eye to an exterior of the eye. The device may include a housing comprising an inlet and an outlet, and a pressure relief valve coupled to the housing. The pressure relief valve may be configured to open to allow passage of the aqueous humor from an ingress of the pressure relief valve to an egress of the pressure relief valve in response to a pressure of the aqueous humor on the ingress exceeding a threshold. The device may include a filter configured to allow passage of fluid from the egress through the outlet along a fluid path extending from the inlet to the outlet.

Classes IPC  ?

  • A61F 9/007 - Procédés ou dispositifs pour la chirurgie de l'œil
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs
  • A61N 1/375 - Aménagements structurels, p. ex. boîtiers

15.

APPROACHES TO GENERATING GRAPHICAL USER INTERFACE INDICATORS BASED ON EVALUATIONS OF WEARABLE DEVICE-RELATED ACTIVITY

      
Numéro d'application US2025048670
Numéro de publication 2026/073204
Statut Délivré - en vigueur
Date de dépôt 2025-09-30
Date de publication 2026-04-02
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Liu, Ying Ying
  • Gatti, Anthony
  • Wang, Sophia

Abrégé

A platform for dynamically generating a visual scheme of a graphical user interface to indicate compliance with study requirements is disclosed herein. The platform can receive device data corresponding to a first time period. The platform can generate a first compliance indicator associated with a first data type of the device data. The platform can generate a second compliance indicator associated with a second data type of the device data. The platform can generate a third compliance indicator associated with a third data type of the device data. The platform can generate an overall compliance indicator based on the first, second, and third compliance indicators. The platform can generate a first visual representation of the overall compliance indicator in a first color or in a second color based on the value of the overall compliance indicator.

Classes IPC  ?

  • G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
  • G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance

16.

Pattern discovery in continuous glucose monitoring data

      
Numéro d'application 17026029
Numéro de brevet 12588838
Statut Délivré - en vigueur
Date de dépôt 2020-09-18
Date de la première publication 2026-03-31
Date d'octroi 2026-03-31
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Shoeb, Ali
  • Biesinger, William Jacob Benhardt
  • Burkart, Joshua

Abrégé

Introduced here are diabetes management platforms able to examine glucose measurements associated with a subject to discover patterns indicative of similar behaviors/circumstances. More specifically, a diabetes management platform can acquire multiple data series generated by a glucose monitoring device that monitors the blood glucose level of an individual over multiple time intervals. The diabetes management platform can then apply a similarity algorithm to produce a distance measure (also referred to as a “similarity measure”) for each data series. For example, the diabetes management platform may, for each data series, perform dynamic time warping to produce a distance measure with respect to each of the other data series. The diabetes management platform can identify patterns indicative of similar behaviors/circumstances based on these distance measures.

Classes IPC  ?

  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • G06F 16/28 - Bases de données caractérisées par leurs modèles, p. ex. des modèles relationnels ou objet
  • G09B 5/02 - Matériel à but éducatif à commande électrique avec présentation visuelle du sujet à étudier, p. ex. en utilisant une bande filmée
  • G09B 19/00 - Enseignement non couvert par d'autres groupes principaux de la présente sous-classe
  • G16H 80/00 - TIC spécialement adaptées pour faciliter la communication entre les professionnels de la santé ou les patients, p. ex. pour le diagnostic collaboratif, la thérapie collaborative ou la surveillance collaborative de l’état de santé

17.

BODY-MOUNTABLE TEMPERATURE MONITOR ACCOUNTING FOR AMBIENT CONDITIONS

      
Numéro d'application 19408118
Statut En instance
Date de dépôt 2025-12-03
Date de la première publication 2026-03-26
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Heitz, Roxana
  • Biederman, William
  • Frick, Sean

Abrégé

A method of monitoring an internal body temperature of a patient includes detecting a skin temperature of the patient using a temperature sensor in a body-mountable temperature monitor attached to the patient; calculating, using the temperature sensor, a heat flux associated with the body-mountable temperature monitor based on selectively activating a heater in the body-mountable temperature monitor; and determining the internal body temperature of the patient using the skin temperature and the heat flux.

Classes IPC  ?

  • G01K 13/20 - Thermomètres médicaux par contact pour les humains ou les animaux
  • G01K 1/14 - SupportsDispositifs de fixationDispositions pour le montage de thermomètres en des endroits particuliers
  • G01K 1/143 - SupportsDispositifs de fixationDispositions pour le montage de thermomètres en des endroits particuliers pour la mesure de la température de surfaces
  • G01K 1/20 - Compensation des effets des variations de température autres que celles à mesurer, p. ex. variations de la température ambiante
  • G01K 7/22 - Mesure de la température basée sur l'utilisation d'éléments électriques ou magnétiques directement sensibles à la chaleur utilisant des éléments résistifs l'élément étant une résistance non linéaire, p. ex. une thermistance

18.

TRAINING MODELS TO COMBINE MEASURES FOR DETECTING DISEASE PROGRESSION

      
Numéro d'application US2025046945
Numéro de publication 2026/064496
Statut Délivré - en vigueur
Date de dépôt 2025-09-18
Date de publication 2026-03-26
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Ho, King Chung
  • Kowahl, Nathan
  • Chen, Chen
  • Shin, Sooyoon
  • Rainaldi, Erin
  • Amenos, Claudia Serrano

Abrégé

Introduced here is an approach for training machine learning models to generate combined measures to detect disease progression. Methods and systems discussed herein generate combined measures in a supervised or unsupervised manner using single measures derived from higher-frequency, longitudinal free-living data (or simply "free-living data") or lower-frequency, controlled-setting data, such as virtual motor exam (VME) data or gait analysis data. By generating combined measures, these models can more accurately detect disease progression, capturing a more comprehensive view of the patient's condition.

Classes IPC  ?

  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux

19.

A SYSTEM FOR MONITORING DATA QUALITY DURING A RESEARCH STUDY OR FROM A CARE SETTING USING PERSONAL DEVICES

      
Numéro d'application US2025038452
Numéro de publication 2026/059652
Statut Délivré - en vigueur
Date de dépôt 2025-07-21
Date de publication 2026-03-19
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Rainaldi, Erin
  • Ingarsal, Sowmya
  • Aristizabal, David
  • Whitney, Holly
  • Janke, Devon
  • Cheng, Li-Fang
  • Van Dyke, Caleb

Abrégé

A technique for monitoring data quality during a research study or from a care setting using body wearable monitors includes storing sensor data, received from the body wearable monitors worn by participants in the research study, into a database. Data quality metrics for the sensor data are derived by determining whether the sensor data falls within specified value ranges. The sensor data stored within the database is annotated with the data quality metrics. Data quality decisions for the sensor data are generated based on data quality rules specified for the research study and applied to the sensor data and the data quality metrics. The data quality decisions are monitored in real-time or on a periodic schedule and a data quality alert is issued when one or more of the data quality decisions falls outside of an acceptable limit specified for the research study.

Classes IPC  ?

  • G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
  • G16H 40/67 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement à distance

20.

Valence profiling of virtual interactive objects

      
Numéro d'application 18061560
Numéro de brevet 12573479
Statut Délivré - en vigueur
Date de dépôt 2022-12-05
Date de la première publication 2026-03-10
Date d'octroi 2026-03-10
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Peterson, Bret
  • Walter, Collin
  • Fromer, Merle
  • Hsin, Honor

Abrégé

Introduced here are health management platforms able to infer the health state of a subject based on behavioral changes reflected in the digital activities performed by a subject. A health management platform can initially acquire contextual data pertaining to digital activities performed by the subject. The health management platform can identify the target(s) of the digital activities by parsing the contextual data, and then compile the digital activities and corresponding activities into a personalized valence index. Thereafter, the health management platform can compare digital activities performed by the subject to the entries included in the personalized valence index. If a matching entry is not discovered, the health management platform can identify an instance of behavior change. These instances of behavior change may be indicative of changes in the subject's health state.

Classes IPC  ?

  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G06F 16/951 - IndexationTechniques d’exploration du Web
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux

21.

Valence profiling of virtual interactive objects

      
Numéro d'application 18600551
Numéro de brevet 12567487
Statut Délivré - en vigueur
Date de dépôt 2024-03-08
Date de la première publication 2026-03-03
Date d'octroi 2026-03-03
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Peterson, Bret
  • Walter, Collin
  • Fromer, Merle
  • Hsin, Honor

Abrégé

Introduced here are health management platforms able to infer the health state of a subject based on behavioral changes reflected in the digital activities performed by a subject. A health management platform can initially acquire contextual data pertaining to digital activities performed by the subject. The health management platform can identify the target(s) of the digital activities by parsing the contextual data, and then compile the digital activities and corresponding activities into a personalized valence index. Thereafter, the health management platform can compare digital activities performed by the subject to the entries included in the personalized valence index. If a matching entry is not discovered, the health management platform can identify an instance of behavior change. These instances of behavior change may be indicative of changes in the subject's health state.

Classes IPC  ?

  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G06F 16/951 - IndexationTechniques d’exploration du Web
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux

22.

PRE

      
Numéro d'application 247943400
Statut En instance
Date de dépôt 2026-02-12
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (1) Telecommunications access services; telecommunication services provided via Internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. (2) Research services in the field of data analytics and machine learning, namely analysis of technical data relating to clinical trials, laboratory and genomics; data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SaaS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (3) Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks.

23.

PRE

      
Numéro d'application 248711000
Statut En instance
Date de dépôt 2026-02-12
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (1) Telecommunications access services; telecommunication services provided via Internet platforms in the field of health; providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. (2) Research services in the field of data analytics and machine learning, namely analysis of technical data relating to clinical trials, laboratory and genomics; data mining; scientific research and machine software and artificial intelligence programming and technology consulting in the fields of drug development, personalized medicine and patient care pathways; artificial intelligence as a service (AIaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SaaS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SaaS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways. (3) Healthcare services, namely, medical counseling services and treatment monitoring using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultation rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks.

24.

Health event highlighter

      
Numéro d'application 18454728
Numéro de brevet 12547293
Statut Délivré - en vigueur
Date de dépôt 2023-08-23
Date de la première publication 2026-02-10
Date d'octroi 2026-02-10
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Wright, David

Abrégé

Introduced here is a method, a system, a device, etc. for displaying health-related data (e.g., blood glucose measurements) relevant to user's selection. The method, the system, the device, etc. can be based on: receiving healthcare-related data from data streams associated with a profile of a patient; identifying, based on a least a subset of the data streams, a time window corresponding to a contextual event indicative of a patient activity that has a potential of affecting metabolism of the patient; determining a graphical representation of the contextual event; generating a graph of blood glucose level over time for display; detecting a user indication of a user interest in a time point along the graph of the blood glucose level; and highlighting the graphical representation of the contextual event in response to the time point falling within the identified time window.

Classes IPC  ?

  • G06F 3/04817 - Techniques d’interaction fondées sur les interfaces utilisateur graphiques [GUI] fondées sur des propriétés spécifiques de l’objet d’interaction affiché ou sur un environnement basé sur les métaphores, p. ex. interaction avec des éléments du bureau telles les fenêtres ou les icônes, ou avec l’aide d’un curseur changeant de comportement ou d’aspect utilisant des icônes
  • G06F 9/451 - Dispositions d’exécution pour interfaces utilisateur
  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
  • G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux

25.

SUBJECT INTERFACE FOR RETINAL IMAGING SYSTEM

      
Numéro d'application US2025035453
Numéro de publication 2026/029895
Statut Délivré - en vigueur
Date de dépôt 2025-06-26
Date de publication 2026-02-05
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Glassman, Ethan
  • Emken, Jeremy
  • Allen, Michael
  • Lin, Arthur
  • Vu, Van Khoi
  • Grossman, Jonathan

Abrégé

A subject interface including bellows for a retinal imaging system and a retinal imaging are described. In an embodiment, the subject interface comprises a headrest shaped to couple with a forehead of a subject, the headrest comprising a rim defining a headrest aperture; and a bellows comprising an outer circumference coupled to the rim; and an inner circumference defining a bellows aperture overlapping with the headrest aperture. In an embodiment, the bellows is configured to move the inner circumference relative to the outer circumference through deformation of the bellows. In an embodiment, the inner circumference is configured to move relative to the outer circumference to displace the bellows aperture primary axis relative to the headrest aperture primary axis. In an embodiment, the bellows defines one or more waves, shaped to unfold as the bellows aperture primary axis is displaced relative to the headrest primary axis.

Classes IPC  ?

  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil

26.

ENDOSCOPIC SYSTEMS AND METHODS WITH LARGE FIELD OF VIEW AND ARTIFICIAL INTELLIGENCE SUPPORT

      
Numéro d'application 19144298
Statut En instance
Date de dépôt 2024-01-02
Date de la première publication 2026-01-29
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Goldenberg, Roman
  • Talmi, Itamar

Abrégé

Methods and systems of analyzing and displaying medical videos are described herein. In some embodiments, the methods and systems may be used during an endoscopy procedure using a multi-camera endoscope having a first camera and a second camera. A method according to the present disclosure may include: receiving a first medical video from a first camera; receiving a second medical video from a second camera; detecting one or more target features of the second medical video using a pre-trained target feature detector comprising a neural network; generating an alert indicating the detection of the one or more target features in the second medical video; and displaying the first medical video and the alert on a display.

Classes IPC  ?

  • A61B 1/00 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments
  • A61B 1/04 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments combinés avec des dispositifs photographiques ou de télévision
  • A61B 1/31 - Instruments pour procéder à l'examen médical de l'intérieur des cavités ou des conduits du corps par inspection visuelle ou photographique, p. ex. endoscopesDispositions pour l'éclairage dans ces instruments pour le rectum, p. ex. proctoscopes, sigmoïdoscopes

27.

VERILY INTELLIGENCE

      
Numéro d'application 248097000
Statut En instance
Date de dépôt 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; downloadable software using artificial intelligence for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; downloadable software using artificial intelligence for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; downloadable chatbot software using artificial intelligence for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; downloadable software for accessing and refreshing patient medical records from health information exchanges; downloadable software using artificial intelligence for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; downloadable software for clinical trial data collection, storage, and analysis; downloadable software using artificial intelligence for the capture and analysis of health data to improve patient care. (1) Providing online non-downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data in the health, nutrition, wellness, medical, scientific, and pharmaceutical fields; providing online non-downloadable software using artificial intelligence for monitoring, tracking, and analyzing health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data, and demographic data for use in connection with clinical trials, research studies, and health management and treatment; providing online non-downloadable software for diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, appointment scheduling, and setting and monitoring individual health goals; providing temporary use of online non-downloadable chatbot software using artificial intelligence for personalized health and medical recommendations, diet and exercise planning, mental health support, symptom evaluation, medication optimization, personalized health insights, disease and treatment management, vaccination tracking, and setting and monitoring individual health goals; providing online non-downloadable software for accessing and refreshing patient medical records from health information exchanges; providing online non-downloadable software using artificial intelligence for identifying and enrolling in clinical trials and eligible research opportunities based on patient medical history and individual health status; providing online non-downloadable software for clinical trial data collection, storage and analysis; providing online non-downloadable software using artificial intelligence for the capture and analysis of health data to improve patient care. (2) Providing information about health and the management of health conditions; healthcare advisory services; healthcare services in the nature of real time medical diagnosis support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the internet or telecommunication networks; providing personalized healthcare and medical information in the fields of mental health, physical health, nutrition, wellness, diet and exercise, symptom, disease, and treatment management; providing personalized healthcare and medical information for use in optimizing the use of medication for health and wellness treatments by offering data featuring health, medical, genetic, movement, nutritional, wellness, geographic, health risk, and demographic information; medical services in the nature of providing a database featuring health data analytics and care delivery data analytics and insights to patients, doctors, hospitals, and medical professionals for diagnostic and treatment purposes (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); medical diagnostic testing, monitoring, and reporting services; laboratory testing and analysis for diagnostic and population health purposes in the fields of oncology and virology; medical services, namely, screening, diagnosing or grading the severity of a disease or health condition based on image data; medical analysis services for diagnostic and treatment purposes provided by medical laboratories.

28.

VIOLET

      
Numéro d'application 248097100
Statut En instance
Date de dépôt 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (1) Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. (2) Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (3) Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

29.

VERILY VIOLET

      
Numéro d'application 248096900
Statut En instance
Date de dépôt 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (1) Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. (2) Providing temporary use of on-line non-downloadable software and programs using artificial intelligence (AI) for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; providing online non-downloadable software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific, and pharmaceutical fields; providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (3) Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

30.

PRE

      
Numéro d'application 248255600
Statut En instance
Date de dépôt 2026-01-08
Propriétaire Verily Life Sciences LLC (USA)
Classes de Nice  ?
  • 09 - Appareils et instruments scientifiques et électriques
  • 38 - Services de télécommunications
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; downloadable software for collecting, processing, analyzing, transmitting, validating and displaying data using artificial intelligence in the health, medical, scientific and pharmaceutical fields; downloadable software for data analytics using artificial intelligence in the fields of drug discovery, personalized medicine and patient care pathways; downloadable computer software using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; downloadable software for patient case management using artificial intelligence for viewing and sharing patient health information, performing healthcare data analytics, generating patient insights, and managing patient care; downloadable application programming interface (API) software; downloadable computer software for use as an application programming interface (API); downloadable software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (1) Telecommunications services; telecommunications platform related to health (term considered too vague by the International Bureau pursuant to Rule 13 (2) (b) of the Regulations); providing access to databases; providing access to databases featuring patient health data; providing access to databases featuring medical research data; providing access to databases featuring clinical trial data; providing access to databases featuring health data, medical data, genetic data, movement data, nutritional data, wellness data, geographic data, health risk data and demographic data. (2) Providing data analytics and machine learning services, namely analyzing and organizing clinical, laboratory and genomic data, data mining, scientific research and machine software and artificial intelligence programing and consulting in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software for data analytics in the fields of drug discovery, personalized medicine and patient care pathways; artificial intelligence as a service (AIAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; providing temporary use of on-line non-downloadable software and applications using artificial intelligence (AI) for collecting, processing, analyzing, transmitting, validating and displaying data in the health, medical, scientific and pharmaceutical fields; software as a service (SAAS) services featuring software using artificial intelligence (AI) for data analytics and machine learning in the fields of drug development, personalized medicine and patient care pathways; application service provider featuring application programming interface (API) software; software as a service (SAAS) services featuring software for identity and authorization management in the health, medical, scientific and pharmaceutical fields. (3) Healthcare services in the nature of real time support services, health recommendations using artificial intelligence, and treatment tracking using artificial intelligence, algorithm-based machine learning, and analysis technologies; medical advisory services; medical counseling; medical services; healthcare; providing healthcare information; online medical consultations rendered in virtual environments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.

31.

Retinal cameras having movable optical assemblies for facilitating multi-stage retinal imaging

      
Numéro d'application 18619806
Numéro de brevet 12514446
Statut Délivré - en vigueur
Date de dépôt 2024-03-28
Date de la première publication 2026-01-06
Date d'octroi 2026-01-06
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Lubin, James K.
  • Kramer, Ryan

Abrégé

Introduced here are retinal cameras having one or more optical components whose position can be modified so that the left and right eyes can be imaged during a single imaging operation. Collectively, the optical component(s) may be referred to as an “optical assembly.” An optical assembly can include the objective lens, lens tube, and other optical components such as mirror(s), light source(s), capturing medium(s), etc. An optical assembly of a retinal camera may be movable between a first position and a second position along an arcuate path. By moving the optical assembly between the first and second positions along the arcuate path, the retinal camera can align the lens tube with the left and right eyes of an individual while clearing her nose. Thus, the retinal camera may generate images of the left and right eyes during an imaging procedure without requiring that the individual move her head.

Classes IPC  ?

  • A61B 3/15 - Dispositions spécialement adaptées à la photographie de l'œil avec des moyens d'alignement, d'espacement ou de suppression des réflexions parasites
  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes

32.

Discovering and annotating segments of physiological data corresponding to changes in disease state

      
Numéro d'application 17814754
Numéro de brevet 12514515
Statut Délivré - en vigueur
Date de dépôt 2022-07-25
Date de la première publication 2026-01-06
Date d'octroi 2026-01-06
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Biesinger, William Jacob Benhardt
  • Burkart, Joshua

Abrégé

Introduced here are diabetes management platforms able to make annotations to physiological data of a subject whose glycemic health state is being monitored. These annotations can be used to classify excursions detected in the physiological data to facilitate the identification of a therapeutic behavior change intended to improve the glycemic health state of the subject. For example, a health coach may review the annotation(s) associated with the subject before generating a recommendation for improving the glycemic health state. As another example, the diabetes management platform can automatically identify an appropriate recommendation based on the annotation(s).

Classes IPC  ?

  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local

33.

SYSTEMS AND METHODS FOR COMBINING ACTIGRAPHY DATA WITH HEART RATE DATA TO ENHANCE SLEEP STAGING

      
Numéro d'application US2025035112
Numéro de publication 2026/006350
Statut Délivré - en vigueur
Date de dépôt 2025-06-25
Date de publication 2026-01-02
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Saeb Taheri, Sohrab
  • Verma, Nishant

Abrégé

The sleep staging platform disclosed herein enables accurate sleep stage classification by combining actigraphy data with heart rate data. The platform may use a multi-model approach that includes a first machine learning model to evaluate sleep stages using heart rate patterns from polysomnography datasets related to a wearable device. The platform may combine the outputs of the heart rate-based model with actigraphy features into a second model to further evaluate sleep stages. The platform may segment events based on timestamps to detect sleep stages and calculate clinically relevant sleep metrics such as total sleep time and wake after sleep onset. By using a multi-model approach, the platform reduces feature dimensionality, enabling practical training with small polysomnography datasets related to wearable devices. The combination of heart rate patterns and actigraphy features may enhance sleep staging accuracy, particularly when heart rate data is derived from motion-sensitive polysomnography signals.

Classes IPC  ?

  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

34.

DETECTION, IDENTIFICATION, AND VERIFICATION OF PATIENTS INVOLVED IN DIAGNOSTIC SESSIONS

      
Numéro d'application 19306773
Statut En instance
Date de dépôt 2025-08-21
Date de la première publication 2025-12-25
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Atkinson, Ian
  • Kramer, Ryan
  • Glik, Eliezer
  • Stoertz, Aaron Haywood

Abrégé

Introduced here are approaches to ensuring that digital images generated during diagnostic sessions are properly associated with the appropriate patients. By implementing these approaches, a diagnostic platform can minimize the time needed to manually input information prior to a diagnostic session and improve the accuracy of this information.

Classes IPC  ?

  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • G06V 40/14 - Motifs vasculaires
  • G06V 40/18 - Caractéristiques de l’œil, p. ex. de l’iris
  • G16H 30/20 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le maniement d’images médicales, p. ex. DICOM, HL7 ou PACS

35.

MODEL EYE FOR EVALUATING A RETINAL IMAGING SYSTEM

      
Numéro d'application US2025028455
Numéro de publication 2025/259394
Statut Délivré - en vigueur
Date de dépôt 2025-05-08
Date de publication 2025-12-18
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lu, Bo
  • Kavusi, Sam
  • Bahatt, Dar

Abrégé

A model eye for evaluating a retinal imaging system includes a retinal cup and a resolution target. The retinal cup includes an interior surface having a bowl-like shape to represent a fundus of a human eye. The resolution target is disposed on the interior surface for assessing a spatial resolution of the retinal imaging system. The resolution target includes light and dark contrasting regions with straight edges separating the light and dark contrasting regions. At least two of the straight edges are orthogonal. An array of dark color microfeatures may be disposed in the light contrasting region and an array of light color microfeatures may be disposed in the dark contrasting region. The light and dark color microfeatures are variably sized for assessing the spatial resolution of the retinal imaging system.

Classes IPC  ?

  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • G09B 23/30 - Modèles anatomiques

36.

MOTION-ROBUST CONTINUOUS HEART RATE MEASUREMENT

      
Numéro d'application US2025027810
Numéro de publication 2025/254762
Statut Délivré - en vigueur
Date de dépôt 2025-05-05
Date de publication 2025-12-11
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Verma, Nishant
  • Bennett, Miles
  • Mathy, Charles

Abrégé

A technique of estimating a continuous heart rate of a subject includes acquiring pulsatility data indicative of a cardiac cycle of the subject and motion data indicative of a motion of the subject. Frequency transformations are performed on the pulsatility and motion data over discrete windows of temporal length T to generate a set of windowed spectra. The discrete windows are temporally overlapping and each temporally offset from one another. Heart rate values, each corresponding to one of the windowed spectra, are output using a processing pipeline including one or more neural networks trained to collectively output one of the heart rate values for each windowed spectra. The continuous heart rate is estimated based upon a set of the heart rate values from the discrete windows that are temporally overlapping.

Classes IPC  ?

  • A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
  • G06N 3/044 - Réseaux récurrents, p. ex. réseaux de Hopfield
  • G06N 3/045 - Combinaisons de réseaux
  • G06N 3/0464 - Réseaux convolutifs [CNN, ConvNet]
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux

37.

TECHNIQUES FOR MEASURING HEART RATE ANALYTICS FROM PHOTOPLETHYSMOGRAPHY DATA THAT ARE ROBUST TO MOTION ARTIFACTS

      
Numéro d'application US2025030576
Numéro de publication 2025/250436
Statut Délivré - en vigueur
Date de dépôt 2025-05-22
Date de publication 2025-12-04
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Verma, Nishant
  • Mathy, Charles
  • Bennett, Miles
  • Vagula Booshanam, Akshaya

Abrégé

In some embodiments, a computer-implemented method of measuring heart rate analytics using raw photoplethysmography (PPG) data is provided. A computing system determines a plurality of frequency peaks in the raw PPG data using a Fourier analysis. The computing system determines a plurality of selected frequency peaks from the plurality of frequency peaks. For each selected frequency peak of the plurality of selected frequency peaks, the computing system creates filtered PPG data by applying a frequency of the selected frequency peak as a high-pass filter to the raw PPG data; detects diastole peaks and systole valleys in the filtered PPG data; and performs one or more pulse quality checks on the detected diastole peaks and systole valleys. The computing system uses diastole peaks and systole valleys associated with a lowest selected frequency peak that passed the pulse quality checks to determine a heart rate analytic measurement.

Classes IPC  ?

  • A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

38.

SYSTEM AND METHOD FOR SIGNAL QUALITY MEASUREMENT FOR DIGITAL BIOMARKERS & COMPLIANCE MONITORING

      
Numéro d'application US2025025570
Numéro de publication 2025/244771
Statut Délivré - en vigueur
Date de dépôt 2025-04-21
Date de publication 2025-11-27
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Ganesh, Suhas
  • Bennett, Miles
  • Verma, Nishant

Abrégé

Systems and methods for analyzing a blood volume signal are described. In an example, the method comprises extracting self-normalized features from blood volume signals within a signal window; generating a signal quality prediction based on the self-normalized features to provide a quality prediction score, wherein the quality prediction score is between an upper bound and a lower bound; and generating a health metric score based on the blood volume signals in the signal window if the quality prediction score is above a predetermined threshold. In an example, the blood volume signals are photoplethysmography (PPG) signals. In an example, the method includes identifying a signal quality issue if the quality prediction score is below the predetermined threshold.

Classes IPC  ?

  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/0205 - Évaluation simultanée de l'état cardio-vasculaire et de l'état d'autres parties du corps, p. ex. de l'état cardiaque et respiratoire
  • A61B 5/024 - Mesure du pouls ou des pulsations cardiaques
  • A61B 5/0295 - Mesure du débit sanguin utilisant la pléthysmographie, c.-à-d. par mesure des variations du volume d'une partie du corps induites par la circulation du sang qui traverse cette partie, p. ex. pléthysmographie par impédance
  • A61B 5/08 - Dispositifs de mesure pour examiner les organes respiratoires
  • A61B 5/1455 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des capteurs optiques, p. ex. des oxymètres à photométrie spectrale

39.

SYSTEMS, METHODS, AND DEVICES FOR PHYSIOLOGICAL SIGNAL CONVERSION, CLASSIFICATION, AND/OR VISUALIZATION USING GENERATIVE MODELS

      
Numéro d'application US2025028929
Numéro de publication 2025/240338
Statut Délivré - en vigueur
Date de dépôt 2025-05-12
Date de publication 2025-11-20
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Elad, Michael
  • Rainaldi, Erin
  • Belhasin, Omer
  • Kligvasser, Idan
  • Leifman, George
  • Cohen, Regev
  • Cheng, Li-Fang
  • Verma, Nishant
  • Varghese, Paul
  • Rivlin, Ehud

Abrégé

Systems, methods and devices for physiological signal conversion, classification and diagnosis of medical conditions, and visualization are presented herein. In one embodiment, a method of determining one or more medical conditions based on a physiological signal of a first type is presented. The method includes providing the physiological signal of the first type to a generative model. The method may further include generating, by the generative model, a plurality of physiological signals of a second type from the physiological signal of the first type. The method may further include generating a plurality of classification scores in one-to-one correspondence with the plurality of physiological signals of the second type. The method may further include determining whether a medical condition exists based on the plurality of classification scores.

Classes IPC  ?

  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
  • A61B 5/318 - Modalités électriques se rapportant au cœur, p. ex. électrocardiographie [ECG]
  • A61B 5/327 - Génération de signaux ECG artificiels à partir de signaux mesurés, p. ex. pour pallier l’absence d’électrodes
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/024 - Mesure du pouls ou des pulsations cardiaques

40.

MOTION SENSOR CORRELATION-BASED REST PERIOD DETECTION

      
Numéro d'application US2025020391
Numéro de publication 2025/230648
Statut Délivré - en vigueur
Date de dépôt 2025-03-18
Date de publication 2025-11-06
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Taheri, Sohrab Saeb

Abrégé

In some embodiments, a computer-implemented method of detecting rest states and active states using motion sensor data from a wearable motion sensor is provided. A computing system calculates features based on the motion sensor data. The motion sensor data includes a plurality of axes of motion sensor data. Calculating the features based on the motion sensor data includes calculating correlations between the axes of the plurality of axes of motion sensor data. The computing system calculates entropy of the features, and determines the rest states and the active states based on the entropy of the features.

Classes IPC  ?

  • G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre

41.

SYSTEMS AND METHODS FOR SEGMENTING SURGICAL VIDEOS

      
Numéro de document 03277843
Statut En instance
Date de dépôt 2018-10-17
Date de disponibilité au public 2025-10-31
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Barral, Joëlle
  • Habbecke, Martin
  • Krumins, Antons
  • Levin, Michal
  • Teisseyre, Thomas

Classes IPC  ?

  • A61B 34/20 - Systèmes de navigation chirurgicaleDispositifs pour le suivi ou le guidage d'instruments chirurgicaux, p. ex. pour la stéréotaxie sans cadre
  • G06F 16/738 - Présentation des résultats des requêtes
  • G06V 20/40 - ScènesÉléments spécifiques à la scène dans le contenu vidéo
  • G11B 27/10 - IndexationAdressageMinutage ou synchronisationMesure de l'avancement d'une bande
  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition

42.

RETINAL CAMERAS HAVING MOVABLE OPTICAL STOPS

      
Numéro d'application 19263195
Statut En instance
Date de dépôt 2025-07-08
Date de la première publication 2025-10-30
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Glik, Eliezer
  • Kavusi, Sam
  • Kramer, Ryan
  • Whitehurst, Todd

Abrégé

Introduced here are retinal cameras having optical stops whose size and/or position can be modified to increase the size of the space in which an eye can move while being imaged. In some embodiments, an optical stop is mechanically moved to recover retinal image quality as the subject shifts their eye. In some embodiments, an optical stop is digitally created using a pixelated liquid crystal display (LCD) layer having multiple pixels that are individually controllably. In some embodiments, multiple non-pixelated LCD layers are connected to one another to form a variable transmission stack, and each LCD layer within the variable transmission stack may be offset from the other LCD layers. In such embodiments, the optical stop can be moved by changing which LCD layer is active at a given point in time.

Classes IPC  ?

  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil
  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • G02F 1/1334 - Dispositions relatives à la structure basées sur des cristaux liquides dispersés dans un polymère, p. ex. cristaux liquides micro-encapsulés

43.

METHODS AND SYSTEMS FOR VISUAL FIELD TEST STIMULI PRESENTATION AND SENSITIVITY MAP ESTIMATION

      
Numéro d'application US2024025048
Numéro de publication 2025/221255
Statut Délivré - en vigueur
Date de dépôt 2024-04-17
Date de publication 2025-10-23
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • De Sisternes Garcia, Luis
  • Sinha, Supriyo

Abrégé

A method for performing a visual field test that includes presenting, through a set of light emitters within a visual field test area, a first sequence of light stimuli; receiving, responsive to each light stimulus, a user response; and generating a sensitivity map of a visual field of a user as output of a machine learning (ML) model responsive to the user responses as input. The method includes determining that a subset of emitters are to present a second sequence of light stimuli based on the first predicted sensitivity map; presenting, through the subset of emitters, the second sequence of light stimuli; receiving, responsive to each light stimulus, the user response; and generating a second sensitivity map (e.g., by updating the first sensitivity map) as output of the ML model responsive to the user responses to the first and second sequence of light stimuli as input into the ML model.

Classes IPC  ?

  • A61B 3/024 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour la détermination du champ de vision, p. ex. périmètres

44.

Approaches to hybrid learning of personalized recommendations and interactive digital health system for implementing the same

      
Numéro d'application 18400330
Numéro de brevet 12450230
Statut Délivré - en vigueur
Date de dépôt 2023-12-29
Date de la première publication 2025-10-21
Date d'octroi 2025-10-21
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Jia, Yugang
  • Rashidian, Sina

Abrégé

Introduced here is an interactive digital health system (or simply “interactive system”) that is able to update a knowledge base used to facilitate semi-automated conversations to account for feedback. The interactive system can include a collection of modules that, in operation, can provide or support coaching services in the digital health domain, Upon receiving input indicative of a question from a patient, these modules allow the interactive system to perform language modeling to identify content objects in a knowledge base that are relevant to the question. Moreover, the interactive system may update the knowledge base to account for feedback, thereby making the knowledge base more robust to a broad range of questions.

Classes IPC  ?

  • G06F 16/2453 - Optimisation des requêtes
  • G06F 16/2457 - Traitement des requêtes avec adaptation aux besoins de l’utilisateur

45.

VISUAL ACUITY MEASUREMENT IN VIRTUAL REALITY HEADSET

      
Numéro d'application US2024023339
Numéro de publication 2025/212101
Statut Délivré - en vigueur
Date de dépôt 2024-04-05
Date de publication 2025-10-09
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Azar, Dimitri

Abrégé

An eye examination apparatus comprising: a virtual reality device (104) configured to be worn on a user's head (102), the virtual reality device having a housing (203) containing a lens (208) and a display (214) operable to display an image (216) to an eye (202) of the user; and a long-pass filter (204) arranged between the lens (208) and the eye (202) for examining the eye's ability to see the image (216), the long-pass filter (204) having a first transmission region (226) that transmits a visible light (218) and a near-infrared light (220) to the eye (202) and a second transmission region (228) that transmits the near-infrared light (220) and blocks the visible light (218).

Classes IPC  ?

  • A61B 3/032 - Dispositifs pour présenter des symboles ou des caractères d'épreuve, p. ex. projecteurs de mires
  • A61B 3/10 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil

46.

METHODS TO SCREEN AND QUANTIFY THYROID EYE DISEASE IN A VIRTUAL REALITY HEADSET

      
Numéro d'application US2025019732
Numéro de publication 2025/212246
Statut Délivré - en vigueur
Date de dépôt 2025-03-13
Date de publication 2025-10-09
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • De Sisternes Garcia, Luis
  • Mcguire, Allister F.
  • Kalamkar, Abhijit
  • Azar, Dimitri

Abrégé

One aspect of the disclosure here is a virtual reality headset-based system that performs a vision test or eye examination (exam) in an automated and repeatable manner that quantifies the tested user's degree of, or likelihood of suffering from, a stage of Thyroid Eye Disease, TED. The system may be configured to analyze images of the user's eyes to determine various quantifiable metrics, where these metrics can be used to, for example, determine how the management of the disease is progressing. Other aspects are also described.

Classes IPC  ?

  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • A61B 3/028 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour examen d'acuité visuelleAppareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour la détermination de la réfraction, p. ex. phoromètres
  • A61B 3/11 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la distance interpupillaire ou le diamètre de la pupille
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil
  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • G02B 27/01 - Dispositifs d'affichage "tête haute"
  • G06T 19/00 - Transformation de modèles ou d'images tridimensionnels [3D] pour infographie

47.

CAPTURE OF GRID OF CARDINAL IMAGES FOR DETECTION AND MONITORING OF STRABISMUS

      
Numéro d'application US2025021618
Numéro de publication 2025/212346
Statut Délivré - en vigueur
Date de dépôt 2025-03-26
Date de publication 2025-10-09
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Azar, Dimitri
  • Sinha, Supriyo
  • Mcguire, Allister F.

Abrégé

An eye examination apparatus comprising: a virtual reality device configured to be worn on a user's head, the virtual reality device having a housing and a display operable to display a fixation point to an eye of the user that corresponds to any one of a number of diagnostic gaze positions; and an imaging device coupled to the housing that is operable to capture an image of the eye viewing the fixation point for use in examining the eye for an ocular condition.

Classes IPC  ?

  • A61B 3/08 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour examen de vision binoculaire ou stéréoscopique, p. ex. pour le contrôle du strabisme
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • G02B 27/01 - Dispositifs d'affichage "tête haute"
  • G06T 19/00 - Transformation de modèles ou d'images tridimensionnels [3D] pour infographie

48.

Digital characterization of movement to detect and monitor disorders

      
Numéro d'application 18651523
Numéro de brevet 12419544
Statut Délivré - en vigueur
Date de dépôt 2024-04-30
Date de la première publication 2025-09-23
Date d'octroi 2025-09-23
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Demiralp, Emre

Abrégé

Introduced here are techniques for digitally characterizing the movement of a subject in order to detect the presence of a disorder or monitor the progression of the disorder. More specifically, one or more angular features can be identified that define how certain part(s) of the human body move relative to other part(s) of the human body. These angular feature(s) can be used, for example, to affirmatively diagnose instances of a disorder, eliminate a disorder as the source of symptoms experienced by a subject, generate confidence scores that can be used to assist in diagnosing a subject, monitor disorder progression due to treatment or lack thereof, etc.

Classes IPC  ?

  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
  • G16H 50/50 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour la simulation ou la modélisation des troubles médicaux

49.

SYSTEM, METHOD, AND APPARATUS FOR UNDERLID HOME-BASED MEIBOMIAN GLAND DISEASE TREATMENT VIA RESISTIVE HEATING AND MAGNETIC-BASED MECHANICAL STIMULATION

      
Numéro d'application US2025018975
Numéro de publication 2025/193550
Statut Délivré - en vigueur
Date de dépôt 2025-03-07
Date de publication 2025-09-18
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lee, Shungneng
  • Stowe, Tim

Abrégé

viavia the heating elements.

Classes IPC  ?

  • A61N 2/00 - Magnétothérapie
  • A61N 2/02 - Magnétothérapie utilisant des champs magnétiques produits par des bobines, y compris par des boucles à spire unique ou par des électro-aimants
  • A61N 1/40 - Application de champs électriques par couplage inductif ou capacitif
  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/08 - Aménagements ou circuits de surveillance, de protection, de commande ou d'indication
  • A61H 23/02 - Massage par percussion ou vibration, p. ex. en utilisant une vibration ultrasoniqueMassage par succion-vibrationMassage avec des membranes mobiles à entraînement électrique ou magnétique
  • A61F 7/00 - Appareils de chauffage ou de refroidissement pour traitement médical ou thérapeutique du corps humain

50.

Imputation of blood glucose monitoring data

      
Numéro d'application 18046826
Numéro de brevet 12417835
Statut Délivré - en vigueur
Date de dépôt 2022-10-14
Date de la première publication 2025-09-16
Date d'octroi 2025-09-16
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Burkart, Joshua
  • Beach, Nathan Dickerson

Abrégé

Introduced here are diabetes management platforms able to impute blood glucose level values for a subject whose glycemic health state is being monitored. These imputed values can be used to estimate the glycemic health state of the subject at a given point in time, identify appropriate recommendations for improving the glycemic health state, etc. More specifically, a diabetes management platform can initially acquire one or more explicit data values generated by a glucose monitoring device. The diabetes management platform can then design a statistical model for imputing data values based on the one or more explicit data values. The diabetes management platform may employ several different computational techniques for performing imputation.

Classes IPC  ?

  • G16H 20/60 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant le contrôle de l’alimentation, p. ex. les régimes
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local

51.

SYSTEM, METHOD, AND APPARATUS FOR UNDERLID HOME-BASED MEIBOMIAN GLAND DISEASE TREATMENT VIA RESISTIVE HEATING AND MAGNETIC-BASED MECHANICAL STIMULATION

      
Numéro d'application 18601436
Statut En instance
Date de dépôt 2024-03-11
Date de la première publication 2025-09-11
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lee, Shungneng
  • Stowe, Tim

Abrégé

A system, method, and apparatus is configured to treat MGD by applying resistive heating and magnetic-based mechanical stimulation of the eyelid. The system includes an underlid device configured to be inserted on the surface of the eye under the eyelid, and a stimulator wand configured to be held by the user on or adjacent to the eyelid in the area of the underlid device. The stimulator wand generates radio frequency (RF) energy that is used to induce an electric current in the underlid device, which is used to excite resistive heating elements that generate heat for heating the meibomian glands. The stimulator wand also generates an oscillating magnetic field that attracts ferromagnetic elements on the underlid device and induces oscillatory movement in the underlid device. The oscillatory movement of the underlid device applies a massaging motion to the meibomian glands while, at the same time, heating the glands via the heating elements.

Classes IPC  ?

  • A61N 1/36 - Application de courants électriques par électrodes de contact courants alternatifs ou intermittents pour stimuler, p. ex. stimulateurs cardiaques
  • A61N 1/372 - Aménagements en relation avec l'implantation des stimulateurs

52.

Systems and methods for peel-off detection for low-power electronics

      
Numéro d'application 16791187
Numéro de brevet 12408868
Statut Délivré - en vigueur
Date de dépôt 2020-02-14
Date de la première publication 2025-09-09
Date d'octroi 2025-09-09
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Mirov, Russell
  • Krasnow, Benjamin
  • Schleicher, Brett

Abrégé

Systems and methods for peel-off detection for lower power electronics are disclosed. In one embodiment, a device includes: a housing; sensor electronics disposed within the housing; an electrode positioned to receive a charge and output a control signal upon removal of a material positioned proximate to the electrode; an electronic switch configured to control an electrical connection between a power supply and the sensor electronics; and an amplifier electrically coupled to the electrode and configured to receive the control signal from the electrode and output an amplified signal to change a state of the electronic switch based on the control signal.

Classes IPC  ?

  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • A61B 5/1477 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang en utilisant des procédés chimiques ou électrochimiques, p. ex. par des moyens polarographiques non invasifs
  • G01D 11/24 - Boîtiers

53.

SAMPLE POOLING ASSAY

      
Numéro d'application 18580079
Statut En instance
Date de dépôt 2022-07-14
Date de la première publication 2025-09-04
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Audeh, Mark
  • Paoli, Eric
  • White, Bradley
  • Duong, Dorothea
  • Dwarakanath, Manali
  • Chan-Herur, Vikram
  • Topol, Aaron

Abrégé

Provided herein are compositions and methods for detecting nucleic acids in pooled samples.

Classes IPC  ?

  • C12Q 1/70 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des virus ou des bactériophages
  • C12Q 1/6851 - Amplification quantitative

54.

AUTO-FOCUS FOR RETINAL IMAGING SYSTEM

      
Numéro d'application US2025010457
Numéro de publication 2025/183786
Statut Délivré - en vigueur
Date de dépôt 2025-01-06
Date de publication 2025-09-04
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Gossage, Kirk
  • Huang, Chung-Po

Abrégé

A system, apparatus, and method of operation for focusing a retinal image are described herein. In an embodiment, the retinal imaging system comprises an eyepiece lens assembly; a structured light assembly configured to emit structured illumination light through the eyepiece lens assembly for receipt by an eye positioned adjacent to the eyepiece lens assembly and opposite the structured light assembly; a retinal image sensor optically coupled to the eyepiece lens assembly, wherein the retinal image sensor is positioned to receive the structured illumination light from the eye and is configured obtain a retinal image of a retina of the eye. In an embodiment, the method includes emitting structured illumination light through the eyepiece lens assembly; generating a retinal image based on the structured illumination light received from the retina of the eye; and measuring an edge strength of the structured illumination light from the retinal image.

Classes IPC  ?

  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil

55.

GENERATING STRUCTURED DATA USING MACHINE LEARNING

      
Numéro d'application US2025016095
Numéro de publication 2025/183934
Statut Délivré - en vigueur
Date de dépôt 2025-02-14
Date de publication 2025-09-04
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Jia, Yugang
  • Amar, Jonathan
  • Rashidian, Sina
  • Yang, Eric
  • Li, Nan

Abrégé

Techniques for generating structured data for progress tracking using machine learning (ML) are disclosed. In an example method, a computing system receives a document including a number of pages including unstructured data or an event table. The computing system inputs, to an LLM, a prompt and the pages, in which the prompt includes instructions for identifying event tables. The computing system receives, from the LLM, a subset of pages including the event tables. The computing system identifies, for each event table, one or more event columns. The computing system inputs, to the LLM, a second prompt and the event columns, the second prompt including instructions for determining information about one or more clinical trial events from the event columns. The computing system receives, from the LLM, the information and outputs structured schedule information generated by mapping the information to a representation of a clinical trials schedule.

Classes IPC  ?

  • G06F 16/242 - Formulation des requêtes
  • G06F 16/3329 - Formulation de requêtes en langage naturel
  • G06F 16/35 - PartitionnementClassement
  • G06F 16/9032 - Formulation de requêtes
  • G06F 16/906 - GroupementClassement
  • G16H 10/20 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des essais ou des questionnaires cliniques électroniques

56.

INTRAOCULAR IMPLANT WITH PINHOLE OPTIC

      
Numéro d'application US2025016205
Numéro de publication 2025/183939
Statut Délivré - en vigueur
Date de dépôt 2025-02-17
Date de publication 2025-09-04
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lee, Shungneng
  • Sinha, Supriyo

Abrégé

An intraocular implant that includes a micro-display orientated to present image data onto a retina of an eye of a user when the intraocular implant is inside the eye, and a pinhole optic that is arranged to focus the image data presented by the micro-display onto the retina when the implant is inside the eye.

Classes IPC  ?

  • A61F 2/16 - Lentilles intraoculaires
  • A61F 2/14 - Parties d'yeux, p. ex. cristallins ou implants de cornéeYeux artificiels

57.

Automatic content tagging in videos of minimally invasive surgeries

      
Numéro d'application 16949785
Numéro de brevet 12400750
Statut Délivré - en vigueur
Date de dépôt 2020-11-13
Date de la première publication 2025-08-26
Date d'octroi 2025-08-26
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Jin, Xing
  • Barral, Joëlle

Abrégé

Systems and methods for eye tracking and content tagging in minimally invasive surgical videos are described herein. Minimally invasive surgical videos may be captured while performing robotic surgeries. Robotic surgical systems described herein include robotic arms with interchangeable surgical tools. An endoscope at the end of one of the robotic arms captures video of the surgical procedure. The video is displayed on a display of the surgical system and an eye tracking device captures data corresponding to a gaze direction of the user on the display. Content tags are automatically generated in the image data based on areas of focus of the user. Information within the content tag may be generated based on surgical procedure steps derived from the image data, a log of current surgical procedures, and image data of previous surgical procedures.

Classes IPC  ?

  • G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
  • G06N 5/02 - Représentation de la connaissanceReprésentation symbolique
  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local

58.

Investigation of glycemic events in blood glucose data

      
Numéro d'application 18402670
Numéro de brevet 12396664
Statut Délivré - en vigueur
Date de dépôt 2024-01-02
Date de la première publication 2025-08-26
Date d'octroi 2025-08-26
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Biesinger, William Jacob Benhardt
  • Burkart, Joshua
  • Beach, Nathan Dickerson
  • Cheng, Shih-Yo

Abrégé

To better understand the impact of glycemic events, some entities have begun examining the relationship between the blood glucose level and another physiological parameter. However, this relationship can be difficult to understand. Introduced here are computer programs and associated computer-implemented techniques for discovering glycemic events in a series of data values representative of blood glucose measurements and then altering the measurement schedule of a sensor capable of generating measurements in a dimension other than blood glucose based on the glycemic events. By altering the measurement schedule of the sensor, a diabetes management platform can better understand how, if at all, dimensions other than blood glucose are related to the glycemic health state of a subject whose blood glucose level is being monitored.

Classes IPC  ?

  • G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • G16H 15/00 - TIC spécialement adaptées aux rapports médicaux, p. ex. leur création ou leur transmission
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local

59.

Dosing labels for electronic medication container caps

      
Numéro d'application 17406979
Numéro de brevet 12390401
Statut Délivré - en vigueur
Date de dépôt 2021-08-19
Date de la première publication 2025-08-19
Date d'octroi 2025-08-19
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Steyn, Jasper Lodewyk

Abrégé

One example medication container includes a storage portion enclosing a volume to store medication and having an opening providing access to the volume, a cap configured to releasably couple to and seal the storage portion, the cap including one or more visual indicators; a sensor; and an electronic timer, wherein the sensor is configured to output a signal in response to detecting that the cap is decoupled from the storage portion; and the timer is configured to reset based on the signal and to output one or more signals to activate the one or more visual indicators based on an elapsed time since a most recent resetting of the timer and one or more thresholds; and a label affixed to the cap, the label having one or more markers, the one or more markers corresponding to the one or more visual indicators, the markers indicating dosing times associated with a medication.

Classes IPC  ?

  • G08B 23/00 - Alarmes réagissant à des conditions indésirables ou anormales, non spécifiées
  • A61J 1/03 - Récipients spécialement adaptés à des fins médicales ou pharmaceutiques pour pilules ou comprimés
  • A61J 7/04 - Dispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments, p. ex. distributeurs programmés

60.

PREDICTING IMMUNOTHERAPY OUTCOMES USING DEEP LEARNING

      
Numéro d'application US2025014305
Numéro de publication 2025/170862
Statut Délivré - en vigueur
Date de dépôt 2025-02-03
Date de publication 2025-08-14
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Loo, Jessica
  • Wang, Yang
  • Steiner, Dave
  • Cimermancic, Peter
  • Wong, Pok Fai

Abrégé

Techniques for predicting immunotherapy outcomes using deep learning are disclosed. In an example method, a computing device receives an image of a tissue sample. The computing device classifies, using a first machine learning model, one or more pathological structures in the tissue sample. The computing device generates, using a second machine learning model, an embedded representation for a first pathological structure from the one or more pathological structures. The computing device determines, using a third machine learning model, a prediction relating to an outcome of applying a therapy. Responsive to the prediction exceeding a predetermined threshold, the computing device outputs an indication corresponding to a likelihood of success of the therapy.

Classes IPC  ?

  • G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
  • G06T 7/00 - Analyse d'image
  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
  • G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients

61.

MODEL EYE WITH PATHOLOGY

      
Numéro d'application US2025011829
Numéro de publication 2025/159965
Statut Délivré - en vigueur
Date de dépôt 2025-01-16
Date de publication 2025-07-31
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lu, Bo
  • Kavusi, Sam
  • Bahatt, Dar

Abrégé

A model eye for evaluating a retinal imaging system includes a retinal cup, a corneal plate, and a dummy retina. The retinal cup includes an interior concave surface. The corneal plate mates to the retinal cup to define an interior cavity with the interior concave surface of the retinal cup. The dummy retina is formed from a flexible material layer attached to the interior concave surface. The dummy retina mimics a human retina and the flexible material layer includes a plurality of peripheral notches in a perimeter of the flexible material layer to aid the flexible material layer to conform to the interior concave surface.

Classes IPC  ?

  • G09B 23/30 - Modèles anatomiques
  • A61B 3/12 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour examiner le fond de l'œil, p. ex. ophtalmoscopes
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux

62.

GAS CHROMATOGRAPH-ION MOBILITY SPECTROMETER SYSTEMS AND METHODS

      
Numéro d'application 19040582
Statut En instance
Date de dépôt 2025-01-29
Date de la première publication 2025-07-31
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Krasnow, Benjamin

Abrégé

In one aspect, a gas chromatography-ion mobility spectrometry (GC-IMS) system is disclosed herein. In some embodiments, the GC-IMS system includes a GC column comprising an inlet and an outlet, and a sample delivery system in fluid connection with the inlet of the GC column and configured to provide a sample to the GC column. The GC column is configured to process the sample and produce a processed sample at the outlet. The GC-IMS system may also include an IMS tube. In some embodiments, the IMS tube includes a sample inlet in fluid communication with the outlet of the GC column, a wall that includes an orifice, and an outlet. The sample inlet may be configured to receive a portion of the processed sample. The IMS tube may be configured to analyze a second portion of pressurized gas.

Classes IPC  ?

63.

Auto-normalization for machine learning

      
Numéro d'application 18421940
Numéro de brevet 12373949
Statut Délivré - en vigueur
Date de dépôt 2024-01-24
Date de la première publication 2025-07-29
Date d'octroi 2025-07-29
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Behrooz, Ali
  • Wu, Cheng-Hsun

Abrégé

Systems and methods for using a prediction model jointly with a normalization model to provide prediction results are provided. One example method includes receiving an input image of a tissue sample of a patient and generating a normalized image by applying a normalization model on the input image. The normalization model is configured to generate normalized data using input data for a prediction model, and the prediction model is configured to generate prediction results using normalized data generated by the normalization model. The normalization model and the prediction model are jointly trained. The method further includes generating a prediction of disease severity for the patient by applying the prediction model on the normalized image.

Classes IPC  ?

  • G06T 7/00 - Analyse d'image
  • G06N 3/08 - Méthodes d'apprentissage
  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition

64.

Surgical robotic system configuration

      
Numéro d'application 16949239
Numéro de brevet 12367972
Statut Délivré - en vigueur
Date de dépôt 2020-10-21
Date de la première publication 2025-07-22
Date d'octroi 2025-07-22
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Barral, Joëlle
  • Shuma, James
  • Levin, Michal

Abrégé

Systems and methods for configuring and instructing movement of a surgical device using configuration data from previous surgeries are described herein. Robotic surgical systems described herein include robotic arms with interchangeable surgical tools. The kinematics of the robotic arms are compared against configuration data from previous procedures and differences between the kinematics and the configuration data are identified. The configuration data also includes simulations of robotic surgical systems throughout a procedure. Potential collisions or complications from present and future configurations are identified. The differences and instructions for resolving the differences and potential collisions are presented to a user for correction.

Classes IPC  ?

  • G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
  • A61B 34/32 - Robots chirurgicaux opérant de façon autonome
  • A61B 90/00 - Instruments, outillage ou accessoires spécialement adaptés à la chirurgie ou au diagnostic non couverts par l'un des groupes , p. ex. pour le traitement de la luxation ou pour la protection de bords de blessures
  • G05B 19/4155 - Commande numérique [CN], c.-à-d. machines fonctionnant automatiquement, en particulier machines-outils, p. ex. dans un milieu de fabrication industriel, afin d'effectuer un positionnement, un mouvement ou des actions coordonnées au moyen de données d'un programme sous forme numérique caractérisée par le déroulement du programme, c.-à-d. le déroulement d'un programme de pièce ou le déroulement d'une fonction machine, p. ex. choix d'un programme
  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • G16H 20/40 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des thérapies mécaniques, la radiothérapie ou des thérapies invasives, p. ex. la chirurgie, la thérapie laser, la dialyse ou l’acuponcture
  • G16H 40/63 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement d’équipement ou de dispositifs médicaux pour le fonctionnement local
  • G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne
  • G16H 50/70 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour extraire des données médicales, p. ex. pour analyser les cas antérieurs d’autres patients
  • G16H 70/20 - TIC spécialement adaptées au maniement ou au traitement de références médicales concernant des pratiques ou des directives
  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux

65.

Recognizing hazard events based on sounds of in-home activities

      
Numéro d'application 18637692
Numéro de brevet 12361930
Statut Délivré - en vigueur
Date de dépôt 2024-04-17
Date de la première publication 2025-07-15
Date d'octroi 2025-07-15
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Pathak, Anupam

Abrégé

A disclosed method includes receiving at least an indication of audio data generated based on sound captured by a microphone of a monitoring device. A set of audio event labels are generated by processing the received audio data with a model that includes audio recognition patterns. Each audio event label is generated by matching an audio pattern in the received audio data with an audio pattern of the audio recognition patterns. The method further includes identifying a hazard event type occurring within a time window of the time period by processing the set of audio event labels with a hazard detection model. In response to detecting the hazard event type, a hazard alert is generated and at least an indication of the hazard alert is communicated to an electronic device other than the monitoring device, which is authorized to receive communications from the monitoring device.

Classes IPC  ?

  • G08B 21/04 - Alarmes pour assurer la sécurité des personnes réagissant à la non-activité, p. ex. de personnes âgées
  • G06N 3/08 - Méthodes d'apprentissage
  • G06N 20/00 - Apprentissage automatique
  • G08B 27/00 - Systèmes d'alarme dans lesquels la condition déclenchant l'alarme est signalée par une station centrale à plusieurs sous-stations
  • G10L 15/16 - Classement ou recherche de la parole utilisant des réseaux neuronaux artificiels

66.

Methods and systems for using machine-learning models to estimate peptide-retention time

      
Numéro d'application 16459052
Numéro de brevet 12362041
Statut Délivré - en vigueur
Date de dépôt 2019-07-01
Date de la première publication 2025-07-15
Date d'octroi 2025-07-15
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Cimermancic, Peter

Abrégé

The present disclosure relates to a machine-learning computing system for training and running a machine-learning model to estimate peptide-retention time for a sample. The machine-learning model can be configured to process inputs that characterize an individual peptide and/or amino acids in the peptide and to output an estimated retention time within a liquid-chromatography column for the peptide. The machine-learning model can include an encoder-decoder model. The encoder and/or the decoder can include a neural network. A subset of peptides can then be identified that are associated with estimated retention times within a specific elution time period during which portion of the sample was eluted from a chromatography column, and mass-spectrometry data can be analyzed to determine which of the subset of peptides are present within the sample.

Classes IPC  ?

  • G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
  • G01N 30/86 - Analyse des signaux
  • G01N 30/88 - Systèmes intégrés d'analyse, spécialement adaptés à cet effet, non couverts par un seul des groupes
  • G06N 3/08 - Méthodes d'apprentissage
  • G06N 20/10 - Apprentissage automatique utilisant des méthodes à noyaux, p. ex. séparateurs à vaste marge [SVM]
  • G16B 35/00 - TIC spécialement adaptées aux bibliothèques combinatoires in silico d’acides nucléiques, de protéines ou de peptides

67.

Enteric coating for targeting the duodenum

      
Numéro d'application 17388944
Numéro de brevet 12350380
Statut Délivré - en vigueur
Date de dépôt 2021-07-29
Date de la première publication 2025-07-08
Date d'octroi 2025-07-08
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Kam, Kimberly
  • Sheridan, Martin
  • Diciccio, Angela

Abrégé

A system for targeted delivery of a medicament to the gastrointestinal tract (e.g., selectively to the duodenum) of a subject. The system includes a medicament, a mucoadhesive layer at least partially surrounding the medicament, and an enteric coating encasing the medicament and mucoadhesive layer. The enteric coating comprises a material degradable by a pH of the GI tract and a material digestible by a lipase. Also provided are method of making and using the system for targeted delivery of a medicament to the gastrointestinal tract. Also provided are a system for deploying a medicament-containing needle system using an expanding element. The system includes a medicament-containing needle system and an expanding element within a capsule. The capsule is initially coated with an enteric coating. As the enteric coating degrades the expanding element absorbs fluid that enters the capsule and expands to deploy the medicament-containing needle system from the capsule.

Classes IPC  ?

  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 45/06 - Mélanges d'ingrédients actifs sans caractérisation chimique, p. ex. composés antiphlogistiques et pour le cœur

68.

METHODS OF DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS BY IDENTIFYING INFLAMMATORY INITIATORS

      
Numéro d'application US2024061009
Numéro de publication 2025/137261
Statut Délivré - en vigueur
Date de dépôt 2024-12-19
Date de publication 2025-06-26
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lin, Jack
  • Sanowar, Sarah
  • Kheradpour, Pouya
  • Kim, Charles
  • Franz, Kate
  • Leung, Jacqueline
  • Han, Andrew

Abrégé

Introduced here are methods of diagnosing, treating, and preventing inflammatory disorders, such as rheumatoid arthritis. The methods comprise receiving biological information from the subject on a memory component comprising computer-executable programs.

Classes IPC  ?

  • C12Q 1/6883 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour les maladies provoquées par des altérations du matériel génétique

69.

SYSTEM FOR CONDUCTING EYE EXAMINATIONS FOR VISUAL ACUITY

      
Numéro d'application US2024060737
Numéro de publication 2025/137079
Statut Délivré - en vigueur
Date de dépôt 2024-12-18
Date de publication 2025-06-26
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Chan, Jeremy
  • Sinha, Supriyo

Abrégé

Systems, devices, and methods for conducting an eye examination for visual acuity are provided. In one example, a system may include an optical subsystem positioned in front of one or both eyes of a user. The optical subsystem may comprise a handheld device or a head worn device, a visual indicator, and a plurality of vision modifiers. The system may determine a distance between the optical subsystem and the display based on comparing a fixed size of the visual indicator to a detected size of the visual indicator in an image obtained by a camera. The system may output an eye examination image for visual acuity based on the distance being within a valid range. The eye examination image may include a visual stimulus having an output size determined based on the distance. The system may receive an input from the user indicating a selection of the visual stimulus.

Classes IPC  ?

  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • A61B 3/18 - Agencement de plusieurs appareils pour tester ou examiner les yeux
  • G02B 27/01 - Dispositifs d'affichage "tête haute"

70.

Artificial neural network models for prediction of de novo sequencing of chains of amino acids

      
Numéro d'application 16170158
Numéro de brevet 12340874
Statut Délivré - en vigueur
Date de dépôt 2018-10-25
Date de la première publication 2025-06-24
Date d'octroi 2025-06-24
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Palaniappan, Krishnan
  • Cimermancic, Peter
  • Levy, Roie

Abrégé

The present invention relates to proteomics, and techniques for predicting de novo sequencing of chains of amino acids, such as peptides, proteins, or combinations thereof. Particularly, aspects of the present invention are directed to a computer implemented method that includes obtaining a digital representation of a mass spectrum, the digital representation including a plurality of container elements, encoding, using an encoder portion of a bidirectional recurrent neural network of long short term memory cells and gated recurrent unit cells, each container element as an encoded vector, decoding, using a decoder portion of the bidirectional recurrent neural network, each of the encoded vectors into a sequence of amino acids; and recording the sequence of amino acids as a multi-dimensional data set of amino acids types and a probability of each of the amino acid types in each position of the complete amino acid sequence.

Classes IPC  ?

  • G16B 40/00 - TIC spécialement adaptées aux biostatistiquesTIC spécialement adaptées à l’apprentissage automatique ou à l’exploration de données liées à la bio-informatique, p. ex. extraction de connaissances ou détection de motifs
  • G06N 3/044 - Réseaux récurrents, p. ex. réseaux de Hopfield
  • G06N 3/084 - Rétropropagation, p. ex. suivant l’algorithme du gradient
  • G06N 3/088 - Apprentissage non supervisé, p. ex. apprentissage compétitif
  • G16B 30/00 - TIC spécialement adaptées à l’analyse de séquences impliquant des nucléotides ou des aminoacides
  • G16B 40/10 - Traitement du signal, p. ex. de spectrométrie de masse ou de réaction en chaîne par polymérase

71.

SYSTEM FOR ATTACHING INTRAOCULAR DEVICES TO IRIS TISSUE

      
Numéro d'application 18540483
Statut En instance
Date de dépôt 2023-12-14
Date de la première publication 2025-06-19
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Arcenio, Gregory
  • Rumyantsev, Oleg
  • Azar, Dimitri
  • Chan, Jeremy

Abrégé

An intraocular implant and system comprising: an intraocular device coupled to an attachment mechanism operable to transition between a first configuration and a second configuration to secure the intraocular device to the eye; and a delivery device operable to deliver the intraocular device to the eye and manipulate the attachment mechanism to transition between the first configuration and the second configuration.

Classes IPC  ?

  • A61F 2/14 - Parties d'yeux, p. ex. cristallins ou implants de cornéeYeux artificiels

72.

SYSTEM FOR ATTACHING INTRAOCULAR DEVICES TO IRIS TISSUE

      
Numéro d'application US2023084431
Numéro de publication 2025/128125
Statut Délivré - en vigueur
Date de dépôt 2023-12-15
Date de publication 2025-06-19
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Arcenio, Gregory
  • Rumyantsev, Oleg
  • Azar, Dimitri
  • Chan, Jeremy

Abrégé

An intraocular implant and system comprising: an intraocular device coupled to an attachment mechanism operable to transition between a first configuration and a second configuration to secure the intraocular device to the eye; and a delivery device operable to deliver the intraocular device to the eye and manipulate the attachment mechanism to transition between the first configuration and the second configuration.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main
  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61F 9/007 - Procédés ou dispositifs pour la chirurgie de l'œil

73.

Approaches to verifying the identity of speakers through objective, algorithmic characterizations of voice features and systems for implementing the same

      
Numéro d'application 18670436
Numéro de brevet 12334106
Statut Délivré - en vigueur
Date de dépôt 2024-05-21
Date de la première publication 2025-06-17
Date d'octroi 2025-06-17
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Wang, Rui
  • Campbell, Andrew
  • Schlosser, Danielle
  • Duong, Dan
  • Peterson, Bret
  • Walter, Collin
  • Fromer, Menachem
  • Brant, Arthur
  • Hsin, Honor

Abrégé

Introduced here are approaches to dynamically verifying the identity of an individual and assessing the health of the individual through objective, algorithmic characterizations of voice features derived from audio recordings created by the individual. These voice features may be paralinguistic features, non-linguistic features, or linguistic features. By characterizing these voice features, insights can be gleaned into how events represented in the audio recordings should be emotionally characterized. For example, for each audio recording created by the individual, a health management platform may calculate a valence measure that is based on the voice features established for that audio recording. These valence measures can be documented, for example, in a profile maintained for the individual, such that changes in health can be detected in a more reliable, quantitative manner.

Classes IPC  ?

  • G10L 25/66 - Techniques d'analyse de la parole ou de la voix qui ne se limitent pas à un seul des groupes spécialement adaptées pour un usage particulier pour comparaison ou différentiation pour extraire des paramètres en rapport avec l’état de santé
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/117 - Identification des personnes
  • G10L 17/06 - Techniques de prise de décisionStratégies d’alignement de motifs
  • G10L 25/03 - Techniques d'analyse de la parole ou de la voix qui ne se limitent pas à un seul des groupes caractérisées par le type de paramètres extraits
  • G16H 50/30 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le calcul des indices de santéTIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour l’évaluation des risques pour la santé d’une personne

74.

Two-Phase Deployment-Initiated Wakeup Mechanism For Body-Mountable Electronic Device

      
Numéro d'application 19061762
Statut En instance
Date de dépôt 2025-02-24
Date de la première publication 2025-06-12
Propriétaire
  • DEXCOM, INC. (USA)
  • VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Biederman, Iii, William James
  • Jung, Louis Hyunsuk

Abrégé

The technology described herein is related to a two-phase deployment-initiated wakeup mechanism for a body-mountable electronic device. During a first phase of the two-phase wakeup mechanism, a motion sensor detects an acceleration event indicative of deployment of the device onto the body of the user. During a second phase of the two-phase mechanism, control circuitry can be adapted to be enabled by the acceleration event. Once enabled, the control circuitry can verify that the device has been launched onto the body of a user via a deployment applicator in which the device is retained until deployment. Once verified, the control circuitry can wake up the body-mountable electronic device by transitioning the device from a sleep state to a functional (or operational) state.

Classes IPC  ?

  • G06F 1/3206 - Surveillance d’événements, de dispositifs ou de paramètres initiant un changement de mode d’alimentation
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang

75.

ALIGNMENT DETECTION OF OPHTHALMIC CAMERA SYSTEM

      
Numéro d'application US2024051407
Numéro de publication 2025/117062
Statut Délivré - en vigueur
Date de dépôt 2024-10-15
Date de publication 2025-06-05
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Gossage, Kirk

Abrégé

An ophthalmic camera system includes an eyepiece lens disposed in or on a housing. An image sensor is adapted to acquire a retinal image of the eye through the eyepiece lens. A pupil image sensor acquires an image of a pupil. A controller is coupled to the pupil image sensor for tracking an orientation of the pupil relative to an optical axis of the eyepiece lens. In certain embodiments, the controller fits an ellipse to a periphery of the pupil in the image of the pupil; determines elliptical parameters of the ellipse; and determines a gaze angle of the eye based on the elliptical parameters.

Classes IPC  ?

  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • G06V 40/19 - Capteurs à cet effet
  • A61B 3/113 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour déterminer ou enregistrer le mouvement de l'œil

76.

Virtual health coach for facilitating dynamic dosage titration

      
Numéro d'application 18649589
Numéro de brevet 12318218
Statut Délivré - en vigueur
Date de dépôt 2024-04-29
Date de la première publication 2025-06-03
Date d'octroi 2025-06-03
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Roy, Nikhil
  • Drumond, Miguel Angelo

Abrégé

A computer-implemented method improves efficacy of diabetes self-management to obtain a measurement message and/or contextual activity information used to determine a suitable insulin dosage to treat a patient. The method includes simulating a health coach in a natural conversation to obtain a measurement of the patient's blood-glucose level, processing the measured blood-glucose level with a personalized insulin titration algorithm to determine an insulin dosage recommendation, and generating an electronic signal configured to cause a corresponding action to be performed by a computing device.

Classes IPC  ?

  • G16H 20/17 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients administrés par perfusion ou injection
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • G06F 40/30 - Analyse sémantique
  • G06V 10/70 - Dispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique
  • G16H 20/10 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients
  • H04L 51/02 - Messagerie d'utilisateur à utilisateur dans des réseaux à commutation de paquets, transmise selon des protocoles de stockage et de retransmission ou en temps réel, p. ex. courriel en utilisant des réactions automatiques ou la délégation par l’utilisateur, p. ex. des réponses automatiques ou des messages générés par un agent conversationnel
  • G06Q 50/00 - Technologies de l’information et de la communication [TIC] spécialement adaptées à la mise en œuvre des procédés d’affaires d’un secteur particulier d’activité économique, p. ex. aux services d’utilité publique ou au tourisme
  • H04W 88/02 - Dispositifs terminaux

77.

Approaches to improving the reliability of wireless connections between medication containers and central computing devices

      
Numéro d'application 17669566
Numéro de brevet 12322486
Statut Délivré - en vigueur
Date de dépôt 2022-02-11
Date de la première publication 2025-06-03
Date d'octroi 2025-06-03
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Folkerts, Madeline
  • Steyn, Jasper Lodewyk

Abrégé

Introduced here are computer programs and associated computer-implemented techniques for establishing and then maintaining robust wireless communication channels established in accordance with short-range communication protocols. At a high level, two approaches to improving the reliability of these wireless communication channels are described herein. The first approach involves implementing a synchronization scheme in which data is transferred from the container as a series of messages that are arranged in order of increasing payload size and/or decreasing payload priority. The second approach involves employing a wrapper function that is programmed to track the status of wireless connectivity on a more granular level than traditional operating systems.

Classes IPC  ?

  • G16H 20/13 - TIC spécialement adaptées aux thérapies ou aux plans d’amélioration de la santé, p. ex. pour manier les prescriptions, orienter la thérapie ou surveiller l’observance par les patients concernant des médicaments ou des médications, p. ex. pour s’assurer de l’administration correcte aux patients delivrés par des distributeurs
  • A61J 7/00 - Dispositifs pour administrer les médicaments par voie buccale, p. ex. cuillèresDispositifs pour compter les pilulesDispositions pour l'indication ou le rappel du moment où l'on doit prendre des médicaments
  • H04W 4/35 - Services spécialement adaptés à des environnements, à des situations ou à des fins spécifiques pour la gestion de biens ou de marchandises
  • H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie

78.

WORKFLOW ENHANCEMENT IN SCREENING OF OPHTHALMIC DISEASES THROUGH AUTOMATED ANALYSIS OF DIGITAL IMAGES ENABLED THROUGH MACHINE LEARNING

      
Numéro d'application 18841349
Statut En instance
Date de dépôt 2023-03-08
Date de la première publication 2025-05-29
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Kavusi, Sam

Abrégé

Introduced here are approaches to assessing digital images generated during image capture sessions using a machine learning model so as to stratify patients for examination. By applying the machine learning model to the digital images, the patients that are most in need of further examination can be identified to graders. For example, outputs produced by the diagnostic model may trigger the generation and transmission of notifications for patients that are deemed to warrant further examination.

Classes IPC  ?

  • G16H 50/20 - TIC spécialement adaptées au diagnostic médical, à la simulation médicale ou à l’extraction de données médicalesTIC spécialement adaptées à la détection, au suivi ou à la modélisation d’épidémies ou de pandémies pour le diagnostic assisté par ordinateur, p. ex. basé sur des systèmes experts médicaux
  • G06T 7/00 - Analyse d'image

79.

HOUSING CONSTRUCTION FOR SNAP-IN RETENTION

      
Numéro d'application 19030350
Statut En instance
Date de dépôt 2025-01-17
Date de la première publication 2025-05-22
Propriétaire
  • DEXCOM, INC. (USA)
  • VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Lin, Arthur
  • Frick, Sean

Abrégé

Introduced here is an attachable unit that connects to a base unit through a snap-fitting mechanism. The attachable unit can include a top housing structure and a bottom housing structure that are ultrasonically welded together. The top housing structure can include the toe portion that is integral with remaining portions of the top housing structure, where the toe portion is configured to provide the snap-fit with the base unit.

Classes IPC  ?

  • H05K 5/00 - Enveloppes, coffrets ou tiroirs pour appareils électriques
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • H05K 5/06 - Enveloppes scellées hermétiquement
  • H05K 5/10 - Enveloppes, coffrets ou tiroirs pour appareils électriques comprenant plusieurs parties formant une enveloppe fermée

80.

Protective structures with integrated electrical interconnects for active implantable medical devices

      
Numéro d'application 17470565
Numéro de brevet 12309954
Statut Délivré - en vigueur
Date de dépôt 2021-09-09
Date de la première publication 2025-05-20
Date d'octroi 2025-05-20
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Loo, Alexander
  • Kaplan, Ellen

Abrégé

The present disclosure relates to implantable medical devices having protective structures with integrated electrical interconnects. Particularly, aspects of the present disclosure are directed to a medical device that includes a first nest portion and a second nest portion mateable with the first nest portion to form a nest housing. The nest housing includes an interior surface and an exterior surface with a component cavity defined by the interior surface. An electronics module is disposed within a first region of the component cavity. A power source is disposed within a second region of the component cavity. An electrical interconnect is formed on or embedded within the first nest portion, the second nest portion, or a combination thereof. The electrical interconnect electrically connects the electronics module to the power source.

Classes IPC  ?

  • H05K 5/00 - Enveloppes, coffrets ou tiroirs pour appareils électriques
  • H05K 5/02 - Enveloppes, coffrets ou tiroirs pour appareils électriques Détails
  • H05K 5/10 - Enveloppes, coffrets ou tiroirs pour appareils électriques comprenant plusieurs parties formant une enveloppe fermée

81.

ACTIVATING A PASS THROUGH MODE OF A HEADSET BASED ON EYE PATTERN

      
Numéro d'application US2024053521
Numéro de publication 2025/101397
Statut Délivré - en vigueur
Date de dépôt 2024-10-30
Date de publication 2025-05-15
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Sinha, Supriyo

Abrégé

Disclosed is a system for monitoring one or both eyes of a user. The system includes a headset worn by the user and one or more processors. The headset includes a display to generate an output which the user can see while wearing the headset and an eye tracking subsystem to track one or both eyes of the user. The headset can operate alternately in a virtual reality (VR) mode and in a pass through mode. The one or more processors can detect, via the eye tracking subsystem, an eye pattern of one or both eyes of the user. The eye pattern can be detected while the headset is operating in the VR mode. The one or more processors can switch the headset from the VR mode to the pass through mode based on detecting the eye pattern. Other aspects are also described and claimed.

Classes IPC  ?

  • G06F 3/01 - Dispositions d'entrée ou dispositions d'entrée et de sortie combinées pour l'interaction entre l'utilisateur et le calculateur
  • G02B 27/01 - Dispositifs d'affichage "tête haute"
  • A61B 3/02 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient
  • G06T 19/00 - Transformation de modèles ou d'images tridimensionnels [3D] pour infographie

82.

Smart diaper pail

      
Numéro d'application 16948446
Numéro de brevet 12297041
Statut Délivré - en vigueur
Date de dépôt 2020-09-18
Date de la première publication 2025-05-13
Date d'octroi 2025-05-13
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Schiffer, Brian

Abrégé

A diaper pail is disclosed. The diaper pail includes a scale configured to determine a weight of an absorbent article. The diaper pail further includes a light source positioned to transmit light at an excitation wavelength of a biological substance. The diaper pail further includes a photodetector positioned to detect a measurement of light intensity within the range of emission wavelengths of the biological substance. The diaper pail includes a processor that is configured to execute processor-executable instructions to receive the weight of the absorbent article and the measurement of light intensity and to detect a presence of the biological substance on the absorbent article.

Classes IPC  ?

  • B65F 1/16 - Capots ou couvercles
  • B65F 1/14 - Autres caractéristiques de structure
  • G01G 19/52 - Appareils de pesée combinés avec d'autres objets, p. ex. avec de l'ameublement
  • G01G 19/62 - Appareils de pesée indiquant qu'un poids déterminé n'est pas atteint ou qu'il est dépassé
  • G01N 21/64 - FluorescencePhosphorescence
  • G08B 13/14 - Déclenchement mécanique par l'enlèvement ou les essais de déplacement d'articles portatifs

83.

Suggesting behavioral adjustments based on physiological responses to stimuli on electronic devices

      
Numéro d'application 18161400
Numéro de brevet 12299976
Statut Délivré - en vigueur
Date de dépôt 2023-01-30
Date de la première publication 2025-05-13
Date d'octroi 2025-05-13
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Rainaldi, Erin

Abrégé

Introduced here are health management platforms able to monitor changes in the health state of a subject based on the context of digital activities performed by, or involving, the subject. Initially, a health management platform can identify a physiological response by examining physiological data associated with a subject. Then, the health management platform can identify a stimulus presented by an electronic device that provoked the physiological response by examining contextual data associated with the subject. The contextual data may be in the form of a screenshot of a computer program in use by the subject during the physiological response. In some embodiments, the health management platform prompts the subject to specify whether the physiological response is a positive physiological response that resulted in an upward shift in health or a negative physiological response that resulted in a downward shift in health.

Classes IPC  ?

  • G06V 20/40 - ScènesÉléments spécifiques à la scène dans le contenu vidéo
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61B 5/145 - Mesure des caractéristiques du sang in vivo, p. ex. de la concentration des gaz dans le sang ou de la valeur du pH du sang
  • G06T 7/20 - Analyse du mouvement
  • G06V 40/20 - Mouvements ou comportement, p. ex. reconnaissance des gestes
  • G16H 10/60 - TIC spécialement adaptées au maniement ou au traitement des données médicales ou de soins de santé relatives aux patients pour des données spécifiques de patients, p. ex. pour des dossiers électroniques de patients
  • H04W 4/21 - Signalisation de servicesSignalisation de données auxiliaires, c.-à-d. transmission de données par un canal non destiné au trafic pour applications de réseaux sociaux
  • H04W 4/80 - Services utilisant la communication de courte portée, p. ex. la communication en champ proche, l'identification par radiofréquence ou la communication à faible consommation d’énergie

84.

OPHTHALMIC DEVICE WITH A SHIELDING MATERIAL TO PROTECT AGAINST DEGRADATION DURING ACTIVE DRUG RELEASE

      
Numéro d'application US2024053511
Numéro de publication 2025/096506
Statut Délivré - en vigueur
Date de dépôt 2024-10-30
Date de publication 2025-05-08
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Chou, Tzu-Chieh

Abrégé

An ophthalmic device can be configured for active drug delivery. The ophthalmic device can include a body; a reservoir positioned within the body and configured to store at least one drug; and a metal cap configured to cover an opening of the reservoir. The metal cap can be dissolved by application of an electrical signal, which can actively release the at least one drug from the reservoir upon receipt of an electrical signal and create reaction products. At least one of the electrical signal and the reaction products may cause degradation of the at least one drug. Water from the eye can also cause problems with degradation. Accordingly, a shielding material can be utilized as a barrier or defender to protect the drug from degradation due to the active release.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main
  • A61N 1/04 - Électrodes

85.

VAPORIZED OPHTHALMIC DRUG DELIVERY DEVICE

      
Numéro d'application 18797334
Statut En instance
Date de dépôt 2024-08-07
Date de la première publication 2025-04-24
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Armstrong, Maxim
  • Mcguire, Allister

Abrégé

An eye dropper with sensors that allows for delivery of a specific or controlled dose of a therapeutic agent in vapor form to a patient's eye is provided.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main

86.

MULTIPLE DISCRETE SOURCES FOR OPTICAL INTERROGATION OF PRESSURE SENSOR USING AN ARRAY OF SPOTS

      
Numéro d'application US2024049829
Numéro de publication 2025/076246
Statut Délivré - en vigueur
Date de dépôt 2024-10-03
Date de publication 2025-04-10
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s) Sinha, Supriyo

Abrégé

An intraocular pressure measurement system comprising: an intraocular implant having a pressure sensor implantable in an eye, wherein the pressure sensor defines an optical cavity with a depth that varies based on an intraocular pressure of the eye; and an external reader device having a number of laser light sources configured to emit a plurality of beams and project an array of spots formed from the plurality of beams onto the pressure sensor, and a detector configured to receive a reflection of the array of spots off the pressure sensor that is used to measure the intraocular pressure of the eye.

Classes IPC  ?

  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres
  • A61B 3/15 - Dispositions spécialement adaptées à la photographie de l'œil avec des moyens d'alignement, d'espacement ou de suppression des réflexions parasites

87.

GENERATIVE ARTIFICIAL INTELLIGENCE METHODS, SYSTEMS, AND DEVICES FOR ANONYMIZING MEDICAL VIDEOS WHILE PRESERVING FACIAL INFORMATION

      
Numéro d'application US2024031479
Numéro de publication 2025/071693
Statut Délivré - en vigueur
Date de dépôt 2024-05-29
Date de publication 2025-04-03
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Leifman, George
  • Kligvasser, Idan
  • Ravia, Itay
  • Elad, Michael
  • Rivlin, Ehud

Abrégé

In an exemplary aspect, a method of generating an anonymized video from a source video is disclosed. The method includes generating an image data set comprising a set of landmarks, a set of classifications, and a synthesized feature vector based on a frame of the source video. Generating the image data set may include determining a feature vector based on the frame, and generating the synthesized feature vector as a weighted average of a plurality of feature vectors selected from a subset of feature vectors of a data set, wherein the subset of feature vectors are determined as the closest neighbors to the feature vector from among the data set. The method may further include encoding the image data set to produce an encoded vector; generating a synthesized frame based on the encoded vector; and generating the anonymized video based on the synthesized frame and the source video.

Classes IPC  ?

  • G06T 5/60 - Amélioration ou restauration d'image utilisant l’apprentissage automatique, p. ex. les réseaux neuronaux
  • G06T 7/246 - Analyse du mouvement utilisant des procédés basés sur les caractéristiques, p. ex. le suivi des coins ou des segments
  • G06T 3/00 - Transformations géométriques de l'image dans le plan de l'image
  • G06N 3/02 - Réseaux neuronaux
  • G06V 40/16 - Visages humains, p. ex. parties du visage, croquis ou expressions
  • G06V 10/77 - Traitement des caractéristiques d’images ou de vidéos dans les espaces de caractéristiquesDispositions pour la reconnaissance ou la compréhension d’images ou de vidéos utilisant la reconnaissance de formes ou l’apprentissage automatique utilisant l’intégration et la réduction de données, p. ex. analyse en composantes principales [PCA] ou analyse en composantes indépendantes [ ICA] ou cartes auto-organisatrices [SOM]Séparation aveugle de source
  • G16H 30/40 - TIC spécialement adaptées au maniement ou au traitement d’images médicales pour le traitement d’images médicales, p. ex. l’édition

88.

MODULES FOR SINGLE-CELL DATA CONVERSION TO TRANSFORMED BULK-CELL DATA AND METHODS OF USING THE SAME

      
Numéro d'application US2024047753
Numéro de publication 2025/064862
Statut Délivré - en vigueur
Date de dépôt 2024-09-20
Date de publication 2025-03-27
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Drake, Katherine
  • Han, Andrew
  • Kim, Charles
  • Pan, Qinxin
  • Wang, Yuliang
  • Yuen, Benjamin Thomas Kawehilani

Abrégé

Introduced here is a module for converting single-cell data sets to transformed bulk-cell datasets for use in augmenting single-cell data, identifying cell type subsets, and in assessing factors associated with diseases. Such cell type subsets include immune cell subsets.

Classes IPC  ?

  • C12Q 1/6869 - Méthodes de séquençage
  • C12Q 1/6881 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes pour le typage de tissu ou de cellule, p. ex. sondes d’antigène leucocytaire humain [HLA]
  • G16B 40/10 - Traitement du signal, p. ex. de spectrométrie de masse ou de réaction en chaîne par polymérase
  • G16B 25/00 - TIC spécialement adaptées à l’hybridationTIC spécialement adaptées à l’expression de gènes ou de protéines
  • G16B 40/30 - Analyse de données non supervisée

89.

Systems and methods for simulating medical images using generative adversarial networks

      
Numéro d'application 17447235
Numéro de brevet 12259944
Statut Délivré - en vigueur
Date de dépôt 2021-09-09
Date de la première publication 2025-03-25
Date d'octroi 2025-03-25
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Behrooz, Ali
  • Wu, Cheng-Hsun

Abrégé

One disclosed example method for simulated medical images using GANs includes receiving, by a generative adversarial network (“GAN”), a plurality of training images, the training images associated with an affliction and depicting different stages of progression for the affliction; generating, using the GAN, a latent space based on the training images, the latent space comprising a first set of data points indicating parameters associated with the training images; generating, using the GAN, a second set of data points in the latent space based on simulated images generated from the latent space, the simulated images based at least in part on the first set of data points; after generating the second set of data points: receiving a request for a first simulated image associated with the affliction; and generating and outputting, by the GAN, the first simulated image based on the latent space.

Classes IPC  ?

  • G06F 18/214 - Génération de motifs d'entraînementProcédés de Bootstrapping, p. ex. ”bagging” ou ”boosting”
  • G06F 3/0482 - Interaction avec des listes d’éléments sélectionnables, p. ex. des menus
  • G06F 3/04847 - Techniques d’interaction pour la commande des valeurs des paramètres, p. ex. interaction avec des règles ou des cadrans
  • G06N 3/045 - Combinaisons de réseaux

90.

DETERMINING A STANDOFF DISTANCE TO AN EYE

      
Numéro d'application 18467587
Statut En instance
Date de dépôt 2023-09-14
Date de la première publication 2025-03-20
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Azar, Dimitri
  • Sedaghat Pisheh, Hojr
  • Krasnow, Benjamin

Abrégé

Systems, devices, and methods for determining a standoff distance to an eye are provided. In one example, a system may include a structure along a first axis toward an eye, a linear sensor array, and a light source to emit a beam of light toward the linear sensor array along a second axis. The beam of light may comprise a width such that a first portion of the beam of light illuminates a lateral surface of the eye and a second portion of the beam of light passes in front of the eye. The system may determine, based on a measurement of the second portion, a standoff distance between the structure and the eye along the first axis. Another example may include an ultrasonic transducer assembly to emit an ultrasonic pulse toward the eye and detect a reflection of the pulse to determine the standoff distance.

Classes IPC  ?

  • A61B 3/14 - Dispositions spécialement adaptées à la photographie de l'œil
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux
  • A61B 3/13 - Microscopes ophtalmiques
  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres

91.

DETERMINING A STANDOFF DISTANCE TO AN EYE

      
Numéro d'application US2024045410
Numéro de publication 2025/058926
Statut Délivré - en vigueur
Date de dépôt 2024-09-05
Date de publication 2025-03-20
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Azar, Dimitri
  • Pisheh, Hojr Sedaghat
  • Krasnow, Benjamin

Abrégé

Systems, devices, and methods for determining a standoff distance to an eye are provided. In one example, a system may include a structure along a first axis toward an eye, a linear sensor array, and a light source to emit a beam of light toward the linear sensor array along a second axis. The beam of light may comprise a width such that a first portion of the beam of light illuminates a lateral surface of the eye and a second portion of the beam of light passes in front of the eye. The system may determine, based on a measurement of the second portion, a standoff distance between the structure and the eye along the first axis. Another example may include an ultrasonic transducer assembly to emit an ultrasonic pulse toward the eye and detect a reflection of the pulse to determine the standoff distance.

Classes IPC  ?

  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux

92.

ACTIVE DRUG DISPENSING OPHTHALMIC DEVICE HAVING A CONTROLLER-RESPONDER ARCHITECTURE

      
Numéro d'application 18807692
Statut En instance
Date de dépôt 2024-08-16
Date de la première publication 2025-03-13
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s)
  • Gutierrez, Christian
  • Lee, Shungneng
  • Dastgheib, Alireza

Abrégé

An active drug dispensing ophthalmic device can include a plurality of drug reservoirs, each covered by an electrode, and a controller-responder architecture. Electrodissolution of each electrode and the associated drug release can be governed by a controller via a responder. Employing a controller-responder architecture can reduce the number of connections and separate electrical signals required to actively dispense drugs from each of the plurality of drug reservoirs. The controller can be connected to a plurality of responders via a control line bundle and each of the plurality of responders can deliver signals to the electrode(s) covering a portion of a plurality of drug reservoirs. The controller-responder architecture can also employ a composite electrical communication signal to even further decrease the number of electrical connections required from a controller to each of the responders.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier

93.

FILTER-BASED MULTISPECTRAL FLUORESCENCE MICROSCOPE OPTIMIZED FOR VIRTUAL STAINING

      
Numéro d'application US2024045354
Numéro de publication 2025/054302
Statut Délivré - en vigueur
Date de dépôt 2024-09-05
Date de publication 2025-03-13
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Santori, Charles
  • Gutierrez, Michael
  • Bahatt, Dar
  • Homyk, Andrew
  • Yoshitake, Tadayuki

Abrégé

Systems and methods for filter-based multispectral fluorescence microscope optimized for virtual staining techniques are provided. An example imaging system includes an excitation module, an emission module, and a sample stage configured to support a sample. The excitation module is configured to transmit light to the sample to cause fluorescence that is detectable by the emission module. The excitation module includes dichroic mirrors and light sources arranged in a tree configuration based on the positions of the dichroic mirrors. The emission module is configured to capture the emitted fluorescence from the sample. The emission module includes dichroic mirrors and image sensors, in which each image sensor is configured to receive fluorescence of a particular color emitted from the sample responsive to excitation light of a particular color and are arranged in a tree configuration based on the positions of the dichroic mirrors.

Classes IPC  ?

  • G01N 21/64 - FluorescencePhosphorescence
  • G02B 21/06 - Moyens pour éclairer un échantillon
  • G01J 3/44 - Spectrométrie RamanSpectrométrie par diffusion

94.

DETECTING A VISUAL INDICATOR OF AN OCCLUDER FOR AN EYE EXAMINATION

      
Numéro d'application US2024043108
Numéro de publication 2025/049180
Statut Délivré - en vigueur
Date de dépôt 2024-08-20
Date de publication 2025-03-06
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Kalamkar, Abhijit
  • Sinha, Supriyo
  • Chan, Jeremy
  • Azar, Dimitri

Abrégé

Systems, devices, and methods for detecting a visual indicator of an occluder for an eye examination are provided. In one example, a device may be used to administer an eye examination by detecting, via a camera of the device, a visual indicator located on an occluder while the occluder is covering at least a portion of a user's face. The device can configure a graphical user interface to display, at a display screen of the device, an eye examination administered to the user. The device can output, via the display screen, a result of the eye examination based on information encoded by the visual indicator. In some implementations, the detecting may include detecting an opaque surface of the occluder covering an eye of the user. In some implementations, the detecting may include detecting a lens of the occluder covering an eye of the user.

Classes IPC  ?

  • A61B 3/028 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour examen d'acuité visuelleAppareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure subjective, c.-à-d. appareils de d’examen nécessitant la participation active du patient pour la détermination de la réfraction, p. ex. phoromètres
  • A61B 3/00 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux

95.

RELEASE AND CAPTURE TECHNIQUES FOR INSECT POPULATION MONITORING AND CONTROL

      
Numéro d'application US2024044820
Numéro de publication 2025/050010
Statut Délivré - en vigueur
Date de dépôt 2024-08-30
Date de publication 2025-03-06
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Ohm, Johanna R.
  • White, Bradley
  • Crawford, Jacob E.
  • Buchman, Anna
  • Howell, Paul
  • Kakani, Evdoxia
  • Wasson, Brian
  • Behling, Charles
  • Desnoyer, Mark
  • Snoad, Nigel

Abrégé

Systems and methods implementing release and capture techniques for insect population monitoring and control are disclosed. In an example method for releasing shipped insects, shipping containers for transporting insects are received. For each shipping container, a holding containers is prepared by transferring the insects to the holding container. Sustenance is provided for the insects. The insects are released from each holding container after predetermined amount of time.

Classes IPC  ?

  • A01K 1/08 - Dispositions pour libérer simultanément plusieurs animaux
  • A01M 1/10 - Pièges
  • B65D 81/18 - Réceptacles, éléments d'emballage ou paquets pour contenus présentant des problèmes particuliers de stockage ou de transport ou adaptés pour servir à d'autres fins que l'emballage après avoir été vidés de leur contenu fournissant une ambiance spécifique pour le contenu, p. ex. température supérieure ou inférieure à la température ambiante
  • B65D 83/00 - Réceptacles ou paquets comportant des moyens particuliers pour distribuer leur contenu
  • B65D 85/50 - Réceptacles, éléments d'emballage ou paquets spécialement adaptés à des objets ou à des matériaux particuliers pour organismes vivants, objets ou matériaux sensibles aux changements d'ambiance ou de conditions atmosphériques, p. ex. pour animaux terrestres, oiseaux, poissons, plantes aquatiques, plantes non aquatiques, oignons de fleurs, fleurs coupées ou feuillage
  • A01K 1/03 - Logements pour animaux domestiques ou de laboratoire
  • A01N 63/20 - BactériesSubstances produites par des bactéries ou obtenues à partir de celles-ci
  • A01P 23/00 - Chimiostérilisants
  • A01K 67/033 - NÉCESSITÉS COURANTES DE LA VIE ÉLEVAGE; CHASSE; PIÉGEAGE; PÊCHE ÉLEVAGE; AVICULTURE; APICULTURE; PISCICULTURE; PÊCHE; OBTENTION D'ANIMAUX, NON PRÉVUE AILLEURS; NOUVELLES RACES D'ANIMAUX Élevage ou obtention d'animaux, non prévus ailleurs; Nouvelles races d'animaux Élevage ou obtention d'invertébrés; Nouvelles races d'invertébrés

96.

OPTICAL PRESSURE SENSOR FOR EYE WITH EMBEDDED INTERROGATION SYSTEM

      
Numéro d'application US2023032623
Numéro de publication 2025/048839
Statut Délivré - en vigueur
Date de dépôt 2023-09-13
Date de publication 2025-03-06
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Costello, Benedict
  • Azar, Dimitri

Abrégé

An intraocular implant comprising: a pressure sensor implantable in an eye, wherein the pressure sensor comprises a substrate having a first side coupled to a membrane to define an optical cavity with a depth that varies based on an intraocular pressure of the eye; and an enclosure coupled to a second side of the substrate to define a hermetic cavity comprising a light source and a detector operable to interrogate the pressure sensor and obtain data corresponding to an intraocular pressure of the eye based on the interrogation.

Classes IPC  ?

  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main

97.

Gas chromatograph-ion mobility spectrometer systems and methods

      
Numéro d'application 17852697
Numéro de brevet 12241864
Statut Délivré - en vigueur
Date de dépôt 2022-06-29
Date de la première publication 2025-03-04
Date d'octroi 2025-03-04
Propriétaire Verily Life Sciences LLC (USA)
Inventeur(s) Krasnow, Benjamin

Abrégé

In one aspect, a gas chromatography-ion mobility spectrometry (GC-IMS) system is disclosed herein. In some embodiments, the GC-IMS system includes a GC column comprising an inlet and an outlet, and a sample delivery system in fluid connection with the inlet of the GC column and configured to provide a sample to the GC column. The GC column is configured to process the sample and produce a processed sample at the outlet. The GC-IMS system may also include an IMS tube. In some embodiments, the IMS tube includes a sample inlet in fluid communication with the outlet of the GC column, a wall that includes an orifice, and an outlet. The sample inlet may be configured to receive a portion of the processed sample. The IMS tube may be configured to analyze a second portion of pressurized gas.

Classes IPC  ?

98.

Optical Pressure Sensor for Eye with Embedded Interrogation System

      
Numéro d'application 18455981
Statut En instance
Date de dépôt 2023-08-25
Date de la première publication 2025-02-27
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Sinha, Supriyo
  • Costello, Benedict
  • Azar, Dimitri

Abrégé

An intraocular implant comprising: a pressure sensor implantable in an eye, wherein the pressure sensor comprises a substrate having a first side coupled to a membrane to define an optical cavity with a depth that varies based on an intraocular pressure of the eye; and an enclosure coupled to a second side of the substrate to define a hermetic cavity comprising a light source and a detector operable to interrogate the pressure sensor and obtain data corresponding to an intraocular pressure of the eye based on the interrogation.

Classes IPC  ?

  • A61B 3/16 - Appareils pour l'examen optique des yeuxAppareils pour l'examen clinique des yeux du type à mesure objective, c.-à-d. instruments pour l'examen des yeux indépendamment des perceptions ou des réactions du patient pour mesurer la pression intraoculaire, p. ex. tonomètres
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

99.

ACTIVE DRUG DISPENSING OPHTHALMIC DEVICE HAVING A CONTROLLER-RESPONDER ARCHITECTURE

      
Numéro d'application US2024042752
Numéro de publication 2025/042765
Statut Délivré - en vigueur
Date de dépôt 2024-08-16
Date de publication 2025-02-27
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Gutierrez, Christian
  • Lee, Shungneng
  • Dastgheib, Alireza

Abrégé

An active drug dispensing ophthalmic device can include a plurality of drug reservoirs, each covered by an electrode, and a controller-responder architecture. Electrodissolution of each electrode and the associated drug release can be governed by a controller via a responder. Employing a controller-responder architecture can reduce the number of connections and separate electrical signals required to actively dispense drugs from each of the plurality of drug reservoirs. The controller can be connected to a plurality of responders via a control line bundle and each of the plurality of responders can deliver signals to the electrode(s) covering a portion of a plurality of drug reservoirs. The controller-responder architecture can also employ a composite electrical communication signal to even further decrease the number of electrical connections required from a controller to each of the responders.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main
  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

100.

VAPORIZED OPHTHALMIC DRUG DELIVERY DEVICE

      
Numéro d'application US2024041248
Numéro de publication 2025/038348
Statut Délivré - en vigueur
Date de dépôt 2024-08-07
Date de publication 2025-02-20
Propriétaire VERILY LIFE SCIENCES LLC (USA)
Inventeur(s)
  • Armstrong, Maxim
  • Mcguire, Allister

Abrégé

A therapeutic agent delivery device is provided. The device can include: a vapor chamber configured to be positioned about an eye of a patient to deliver a therapeutic agent in vapor form to a tear film of a patient's eye; a therapeutic agent source comprising a therapeutic agent in communication with the vapor chamber; a heater or vacuum in communication with the vapor chamber and the therapeutic agent source, the heater or vacuum configured to convert the therapeutic agent in the therapeutic agent source into a vapor form; and a controller compartment operably coupled to the vapor chamber and comprising a timer and a microcontroller.

Classes IPC  ?

  • A61F 9/00 - Procédés ou dispositifs pour le traitement des yeuxDispositifs pour mettre en place des verres de contactDispositifs pour corriger le strabismeAppareils pour guider les aveuglesDispositifs protecteurs pour les yeux, portés sur le corps ou dans la main
  • A61F 9/007 - Procédés ou dispositifs pour la chirurgie de l'œil
  1     2     3     ...     12        Prochaine page